35 results on '"Khaksarian, Mojtaba"'
Search Results
2. Effect of fluoxetine treatment on neurotoxicity induced by lysolecithin in male rats
- Author
-
Gholami, Elham, Gholami, Mohammad Reza, Tavakoli, Asadollah, Ahmadi, Mahdie, Rezaian, Jafar, Alipour, Maryam, Chehelcheraghi, Farzaneh, and Khaksarian, Mojtaba
- Subjects
Fluoxetine -- Dosage and administration -- Physiological aspects ,Demyelinating diseases -- Models -- Drug therapy -- Development and progression ,Biological sciences - Abstract
Demyelination disorder is an unusual pathologic event, which occurs in the central nervous system (CNS). Multiple sclerosis (MS) is an inflammatory demyelinating disease that affects the CNS, and it is the leading cause of disability in young adults. Lysolecithin (LPC) is one of the best toxin-induced demyelination models. In this study, a suitable model is created, and the effect of fluoxetine treatment is examined on this model. In this case, it was assumed that daily fluoxetine treatment had increased the endogenous remyelination in the LPC model. This study was focused on investigating the influence of the fluoxetine dose of 5 or 10 mg/kg per day for 1 and 4 weeks on LPC-induced neurotoxicity in the corpus callosum region. It was performed as a demyelinating model in male Wistar rats. After 3 days, fluoxetine was injected intraperitoneally (5 or 10 mg/kg per day) for 1 and 4 weeks in each group. After completing the treatment course, the corpus callosum was removed to examine the gene expression and histological analysis was performed. The results of the histopathological study of hematoxylin and eosin staining of the corpus callosum showed that in 1 and 4-week treatment groups, fluoxetine has reduced the level of inflammation at the LPC injection site (5 and 10 mg/kg per day). Fluoxetine treatment in the luxol fast blue (LFB) staining of the corpus callosum has been led to an increase in myelination capacity in all doses and times. The results of the genetic study showed that the fluoxetine has significantly reduced the expression level of tumor necrosis factor-[alpha], nuclear factor [kappa][beta], and induced nitric oxide synthase in comparison with the untreated LPC group. Also, the fluoxetine treatment has enhanced the expression level of the forkhead box P3 (FOXP3) gene in comparison with the untreated group. Fluoxetine has increased the expression level of myelination and neurotrophic genes such as myelin basic protein (MBP), oligodendrocyte transcription factor 2 (OLIG2), and brain-derived neurotrophic factor (BDNF). The outcomes demonstrated that fluoxetine reduces inflammation and strengthens the endogenous myelination in the LPC-induced demyelination model; however, supplementary studies are required for specifying the details of its mechanisms. Key words: fluoxetine, demyelination, lysolecithin. La maladie demyelinisante est un evenement pathologique inhabituel, qui survient dans le systeme nerveux central (SNC). La sclerose en plaques (SP) fait partie des maladies demyelinisantes inflammatoires qui affectent le SNC et elle represente la principale cause d'incapacite chez les jeunes adultes. La lysolecithine (LPC) constitue l'un des meilleurs modeles de demyelinisation engendree par des toxines. Dans cette etude, nous avons realise un modele approprie a partir duquel nous avons examine l'effet de l'administration de fluoxetine. Dans ce cas, on assumait que l'administration quotidienne de fluoxetine avait entraine une augmentation de la remyelinisation endogene dans le modele de lysolecithine. Cette etude etait centree sur l'influence de la fluoxetine a 5/10 mg/kg/jour pendant 1 et 4 semaines de neurotoxicite engendree par la lysolecithine dans la region du corps calleux. Nous l'avons realisee comme modele de demyelinisation chez des rats Wistar males. Apres une attente de trois jours, nous avons injecte de la fluoxetine par voie intraperitoneale (5/10 mg/kg/jour) pendant une ou quatre semaines dans chaque groupe. Une fois la phase d'administration terminee, nous avons preleve le corps calleux en vue d'examiner l'expression genique et de proceder a une etude histologique. Les resultats de l'etude histopathologique avec la coloration a l'hematoxyline-eosine dans le corps calleux ont montre que dans les groupes d'administration sur une et quatre semaines, la fluoxetine permettait de faire diminuer le degre d'inflammation au point d'injection de la lysolecithine (5 et 10 mg/kg/jour). L'administration de fluoxetine sous coloration du corps calleux a l'aide de la coloration au bleu de luxol rapide (LFB) a mene a une augmentation de la capacite de myelinisation a toutes les doses et sur toutes les periodes. Les resultats de l'etude genetique ont montre que la fluoxetine entrainait une diminution des taux d'expression du facteur de necrose tumorale [alpha], du facteur nucleaire kappa beta, et favorisait la production d'oxyde nitrique synthase inductible de facon nettement plus marquee que dans le groupe LPC sans administration du medicament. De plus, l'administration de fluoxetine permettait de faire augmenter les taux d'expression du gene FOXP3 (pour << forkhead box P3 >>) davantage que dans le groupe sans administration du medicament. La fluoxetine entramait une augmentation des taux d'expression de genes de la myelinisation et neurotropes comme la proteine basale de la myeline (MBP), le facteur de transcription des oligodendrocytes 2 (OLIG2) et le facteur neurotrope derive du cerveau (BDNF). Les resultats ont montre que la fluoxetine entrame une diminution de l'inflammation et une amplification de la myelinisation endogene dans le modele de demyelinisation engendree par la lysolecithine. Cependant, des etudes supplementaires seraient necessaires en vue de preciser les details de ses modes d'action. [Traduit par la Redaction] Mots-cles: fluoxetine, demyelinisation, lysolecithine., Introduction Demyelination disorder is an unusual pathologic event in the central nervous system (CNS), which may result in remyelination. The remyelination leads to the replacement of injured myelin at distances [...]
- Published
- 2022
- Full Text
- View/download PDF
3. Investigation of the phytochemicals and bioactivity potential of essential oil from Nepeta curvidens Boiss. & Balansa
- Author
-
Ashrafi, Behnam, Rashidipour, Marzieh, Gholami, Elham, Sattari, Ehsan, Marzban, Abdolrazagh, Kheirandish, Farnaz, Khaksarian, Mojtaba, Taherikalani, Morovat, and Soroush, Setareh
- Published
- 2020
- Full Text
- View/download PDF
4. Antinociceptive effects of green synthesized copper nanoparticles alone or in combination with morphine
- Author
-
Mahmoudvand, Hossein, Khaksarian, Mojtaba, Ebrahimi, Katrin, Shiravand, Sima, Jahanbakhsh, Sareh, Niazi, Massumeh, and Nadri, Sedigheh
- Published
- 2020
- Full Text
- View/download PDF
5. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- Author
-
Safiri, Saeid, Sepanlou, Sadaf G, Ikuta, Kevin S, Bisignano, Catherine, Salimzadeh, Hamideh, Delavari, Alireza, Ansari, Reza, Roshandel, Gholamreza, Merat, Shahin, Fitzmaurice, Christina, Force, Lisa M, Nixon, Molly R, Abbastabar, Hedayat, Abegaz, Kedir Hussein, Afarideh, Mohsen, Ahmadi, Ayat, Ahmed, Muktar Beshir, Akinyemiju, Tomi, Alahdab, Fares, Ali, Raghib, Alikhani, Mahtab, Alipour, Vahid, Aljunid, Syed Mohamed, Almadi, Majid Abdulrahman Hamad, Almasi-Hashiani, Amir, Al-Raddadi, Rajaa M, Alvis-Guzman, Nelson, Amini, Saeed, Anber, Nahla Hamed, Ansari-Moghaddam, Alireza, Arabloo, Jalal, Arefi, Zohreh, Asghari Jafarabadi, Mohammad, Azadmehr, Abbas, Badawi, Alaa, Baheiraei, Nafiseh, Bärnighausen, Till Winfried, Basaleem, Huda, Behzadifar, Masoud, Behzadifar, Meysam, Belayneh, Yaschilal Muche, Berhe, Kidanemaryam, Bhattacharyya, Krittika, Biadgo, Belete, Bijani, Ali, Biondi, Antonio, Bjørge, Tone, Borzì, Antonio M, Bosetti, Cristina, Bou-Orm, Ibrahim R., Brenner, Hermann, Briko, Andrey Nikolaevich, Briko, Nikolay Ivanovich, Carreras, Giulia, Carvalho, Félix, Castañeda-Orjuela, Carlos A, Cerin, Ester, Chiang, Peggy Pei-Chia, Chido-Amajuoyi, Onyema Greg, Daryani, Ahmad, Davitoiu, Dragos Virgil, Demoz, Gebre Teklemariam, Desai, Rupak, Dianati nasab, Mostafa, Eftekhari, Aziz, El Sayed, Iman, Elbarazi, Iffat, Emamian, Mohammad Hassan, Endries, Aman Yesuf, Esmaeilzadeh, Firooz, Esteghamati, Alireza, Etemadi, Arash, Farzadfar, Farshad, Fernandes, Eduarda, Fernandes, João C, Filip, Irina, Fischer, Florian, Foroutan, Masoud, Gad, Mohamed M, Gallus, Silvano, Ghaseni-Kebria, Fatemeh, Ghashghaee, Ahmad, Gorini, Giuseppe, Hafezi-Nejad, Nima, Haj-Mirzaian, Arvin, Haj-Mirzaian, Arya, Hasanpour-Heidari, Susan, Hasanzadeh, Amir, Hassanipour, Soheil, Hay, Simon I, Hoang, Chi Linh, Hostiuc, Mihaela, Househ, Mowafa, Ilesanmi, Olayinka Stephen, Ilic, Milena D., Innos, Kaire, Irvani, Seyed Sina Naghibi, Islami, Farhad, Jaca, Anelisa, Jafari Balalami, Nader, Jafari delouei, Nastaran, Jafarinia, Morteza, Jahani, Mohammad Ali, Jakovljevic, Mihajlo, James, Spencer L., Javanbakht, Mehdi, Jenabi, Ensiyeh, Jha, Ravi Prakash, Joukar, Farahnaz, Kasaeian, Amir, Kassa, Tesfaye Dessale, Kassaw, Mesfin Wudu, Kengne, Andre Pascal, Khader, Yousef Saleh, Khaksarian, Mojtaba, Khalilov, Rovshan, Khan, Ejaz Ahmad, Khayamzadeh, Maryam, Khazaee-Pool, Maryam, Khazaei, Salman, Khosravi Shadmani, Fatemeh, Khubchandani, Jagdish, Kim, Daniel, Kisa, Adnan, Kisa, Sezer, Kocarnik, Jonathan M, Komaki, Hamidreza, Kopec, Jacek A, Koyanagi, Ai, Kuipers, Ernst J., Kumar, Vivek, La Vecchia, Carlo, Lami, Faris Hasan, Lopez, Alan D, Lopukhov, Platon D, Lunevicius, Raimundas, Majeed, Azeem, Majidinia, Maryam, Manafi, Amir, Manafi, Navid, Manda, Ana-Laura, Mansour-Ghanaei, Fariborz, Mantovani, Lorenzo Giovanni, Mehta, Dhruv, Meier, Toni, Meles, Hagazi Gebre, Mendoza, Walter, Mestrovic, Tomislav, Miazgowski, Bartosz, Miazgowski, Tomasz, Mir, Seyed Mostafa, Mirzaei, Hamed, Mohammad, Karzan Abdulmuhsin, Mohammad Gholi Mezerji, Naser, Mohammadian-Hafshejani, Abdollah, Mohammadoo-Khorasani, Milad, Mohammed, Shafiu, Mohebi, Farnam, Mokdad, Ali H, Monasta, Lorenzo, Moossavi, Maryam, Moradi, Ghobad, Moradpour, Farhad, Moradzadeh, Rahmatollah, Nahvijou, Azin, Naik, Gurudatta, Najafi, Farid, Nazari, Javad, Negoi, Ionut, Nguyen, Cuong Tat, Nguyen, Trang Huyen, Ningrum, Dina Nur Anggraini, Ogbo, Felix Akpojene, Olagunju, Andrew T, Olagunju, Tinuke O, Pana, Adrian, Pereira, David M., Pirestani, Majid, Pourshams, Akram, Poustchi, Hossein, Qorbani, Mostafa, Rabiee, Mohammad, Rabiee, Navid, Radfar, Amir, Rahmati, Marveh, Rajati, Fatemeh, Rawaf, David Laith, Rawaf, Salman, Reiner, Robert C, Jr., Renzaho, Andre M N, Rezaei, Nima, Rezapour, Aziz, Saad, Anas M, Saadatagah, Seyedmohammad, Saddik, Basema, Salehi, Farkhonde, Salehi Zahabi, Saleh, Salz, Inbal, Samy, Abdallah M, Sanabria, Juan, Santric Milicevic, Milena M, Sarveazad, Arash, Satpathy, Maheswar, Schneider, Ione J C, Sekerija, Mario, Shaahmadi, Faramarz, Shabaninejad, Hosein, Shamsizadeh, Morteza, Sharafi, Zeinab, Sharif, Mehdi, Sharifi, Amrollah, Sheikhbahaei, Sara, Shirkoohi, Reza, Siddappa Malleshappa, Sudeep K, Silva, Diego Augusto Santos, Sisay, Mekonnen, Smarandache, Catalin-Gabriel, Soofi, Moslem, Soreide, Kjetil, Soshnikov, Sergey, Starodubov, Vladimir I., Subart, Michelle L., Sullman, Mark JM, Tabarés-Seisdedos, Rafael, Taherkhani, Amir, Tesfay, Berhe etsay, Topor-Madry, Roman, Traini, Eugenio, Tran, Bach Xuan, Tran, Khanh Bao, Ullah, Irfan, Uthman, Olalekan A, Vacante, Marco, Vahedian-Azimi, Amir, Valli, Alessandro, Varavikova, Elena, Vujcic, Isidora S, Westerman, Ronny, Yazdi-Feyzabadi, Vahid, Yisma, Engida, Yu, Chuanhua, Zadnik, Vesna, Zahirian Moghadam, Telma, Zaki, Leila, Zandian, Hamed, Zhang, Zhi-Jiang, Murray, Christopher J L, Naghavi, Mohsen, and Malekzadeh, Reza
- Published
- 2019
- Full Text
- View/download PDF
6. Protective Effects of Honey, Apis mellifera Meda Skorikov, on Ischemia-Reperfusion Induced Muscle Injury/Efectos Protectores de la Miel, Apis mellifera Meda Skorikov, sobre la Lesion Muscular Inducida por Isquemia-Reperfusion
- Author
-
Gholami, Mohammad Reza, Abbaszadeh, Abolfazl, Anbari, Khatereh, Khaksarian, Mojtaba, Shabooni, Fatemeh, Khayat, Zahra Khanipour, Khorramabadi, Reza Mohammadrezaei, and Gharravi, Anneh Mohammad
- Published
- 2020
7. A new and safe method for stereotactically harvesting neural stem/progenitor cells from the adult rat subventricular zone
- Author
-
Aligholi, Hadi, Hassanzadeh, Gholamreza, Azari, Hassan, Rezayat, Seyed Mahdi, Mehr, Shahram Ejtemaei, Akbari, Mohammad, Attari, Fatemeh, Khaksarian, Mojtaba, and Gorji, Ali
- Published
- 2014
- Full Text
- View/download PDF
8. The efficacy of Crocus sativus (Saffron) versus placebo and Fluoxetine in treating depression: a systematic review and meta-analysis
- Author
-
Khaksarian,Mojtaba, Behzadifar,Masoud, Behzadifar,Meysam, Alipour,Maryam, Jahanpanah,Firouzeh, Re,Tania Simona, Firenzuoli,Fabio, Zerbetto,Riccardo, and Bragazzi,Nicola Luigi
- Subjects
meta-analysis ,Saffron ,systematic review ,Psychology Research and Behavior Management ,Fluoxetine ,depression ,Original Research - Abstract
Mojtaba Khaksarian,1,2 Masoud Behzadifar,1 Meysam Behzadifar,3,4 Maryam Alipour,5 Firouzeh Jahanpanah,3 Tania Simona Re,6–8 Fabio Firenzuoli,6 Riccardo Zerbetto,7 Nicola Luigi Bragazzi7–101Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran; 2Department of Physiology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran; 3Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran; 4Department of Epidemiology, Faculty of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran; 5Faculty of Biological Science & Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 6Department of Experimental and Clinical Medicine, Center for Integrative Medicine, Careggi University Hospital, University of Florence, Florence, Italy; 7Centro Studi Terapia della Gestalt (CSTG), Milan, Italy; 8UNESCO Chair “Health Anthropology Biosphere and Healing Systems”, University of Genoa, Genoa, Italy; 9Postgraduate School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy; 10Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal/Child Sciences (DINOGMI), University of Genoa, Genoa, ItalyBackground: Depression represents a serious public health concern, imposing a high burden, both in epidemiological and clinical terms. Crocus sativus (Saffron) is a herbal remedy that has anti-cancer, anti-oxidant, anti-inflammatory and anti-platelet properties. However, the exact mechanisms of Saffron in treating depression are not yet clear. This study was conducted to evaluate the effectiveness of Saffron versus placebo and Fluoxetine in the treatment of depressed patients.Methods: Different bibliographic thesauri, namely the Cochrane Library, Scopus, PubMed/MEDLINE, Centre for Reviews and Dissemination (CRD), EMBASE, and ISI/Web of Science (WoS) were searched up to May 2018. Effect sizes were computed as Standardized Mean Differences (SMD) with their 95% confidence interval (CI). To evaluate the heterogeneity among the studies, I2, test was carried out.Results: Eight studies were included. The SMD was −0.86 (95% CI: −1.73 to 0.00) concerning the comparison of Saffron with placebo. The SMD was found to be 0.11 (95% CI: −0.20 to 0.43) concerning the comparison of Saffron with Fluoxetine. In both sensitivity analyses, the results did not statistically change, confirming the stability of the findings.Conclusion: The findings of this study showed that Saffron administration was well comparable with Fluoxetine and placebo.Keywords: systematic review, meta-analysis, Saffron, Fluoxetine, depression
- Published
- 2019
9. Regulation of connexin 43 and microRNA expression via β2-adrenoceptor signaling in 1321N1 astrocytoma cells
- Author
-
KHAKSARIAN, MOJTABA, MOSTAFAVI, HOSSEIN, SOLEIMANI, MASOUD, KARIMIAN, SEID MORTEZA, GHAHREMANI, MOHAMMAD HASSAN, JOGHATAEE, MOHAMMAD TAGHEE, KHORASHADIZADEH, MOHSEN, ALIGHOLI, HADI, ATTARI, FATEMEH, and HASSANZADEH, GHOLAMREZA
- Published
- 2015
- Full Text
- View/download PDF
10. Protective Effects of Honey, Apis mellifera Meda Skorikov, on Ischemia-Reperfusion Induced Muscle Injury
- Author
-
Gholami, Mohammad Reza, Abbaszadeh, Abolfazl, Anbari, Khatereh, Khaksarian, Mojtaba, Shabooni, Fatemeh, Khayat, Zahra Khanipour, Khorramabadi, Reza Mohammadrezaei, and Gharravi, Anneh Mohammad
- Subjects
Gastrocnemius Muscle ,Ischemia-reperfusion Injury ,Lesión por isquemiareperfusión ,Rat ,Honey ,Miel ,Músculo gastrocnemio ,Rata - Abstract
SUMMARY: Honey is a natural antioxidant that its protective effects have been proven against ischemia-reperfusion (IR) injury. The aim of this study was to evaluate the ameliorative effect of Persian Honey, Apis mellifera meda skorikov, on gastrocnemius muscle IR injury. Eighty adult male Sprague-Dawley rats weighing 250-300 g were used. They were divided into ten groups (N=8 per group). The ischemia was conducted with a silk suture 6-0 using the slipknot technique. All groups were rendered in ischemic for 3 h, and reperfused for various times of 3 days (3-day reperfusion), 7 days (7-day reperfusion), 14 days (14-day reperfusion), and 28 days (28-day reperfusion). Half of the groups had experimental honey (5 %) treatment immediately after ischemia. After reperfusion, the rats, based on the grouping, were killed with high doses of anesthetic, and the gastrocnemius muscles were removed and fixed. After the tissue processing, the evaluation of edema and mast cells infiltration was performed with hematoxylin-eosin and toluidine blue staining, respectively. TNF-α was detected with immunohistochemistry method. The amount of TNF-α as an index of acute inflammatory except the 3rd day significantly decreased on the other day of reperfusion (7th, 147th and 287th days). The mast cells infiltration was significantly decreased on 77th and 147th days. The tissue edema was decreased significantly in honey administrated group in the comparison with placebo groups. Honey administration can reduce damage caused by ischemia-reperfusion in the rat gastrocnemius muscle. RESUMEN: La miel es un antioxidante natural; sus efectos protectores han sido probados contra la lesión por isquemiareperfusión (IR). El objetivo de este estudio fue evaluar el efecto de mejora de la miel persa Apis mellifera meda skorikov, en la lesión por IR del músculo gastrocnemio. Se utilizaron 80 ratas Sprague-Dawley macho adultas con un peso entre 250 y 300 g divididas en diez grupos (N = 8 por grupo). La isquemia se realizó con una sutura de seda 6-0 utilizando la técnica slipknot permaneciendo isquémicos durante 3 h. La reperfusión se realizó durante varios tiempos de 3 días, 7 días (reperfusión de 7 días), 14 días (reperfusión de 14 días) y 28 días (28 días reperfusión). La mitad de los grupos recibió tratamiento experimental con miel (5 %) inmediatamente después de la isquemia. Después de la reperfusión, las ratas, fueron sacrificadas con altas dosis de anestésico, y los músculos gastrocnemios fueron removidos y fijados. Después de procesar el tejido, se realizó la evaluación del edema y la infiltración de mastocitos se realizó con tinción de hematoxilina-eosina y azul de toluidina, respectivamente. TNF-α se detectó con el método de inmunohistoquímica. La cantidad de TNF-α como índice de inflamación inflamatoria aguda, excepto en el tercer día, disminuyó significativamente al día siguiente de la reperfusión (7, 14 y 28 días). La infiltración de mastocitos disminuyó significativamente a los 7 y 14 días. El edema tisular disminuyó significativamente en el grupo administrado con miel en comparación con los grupos placebo. El tratamiento con miel puede reducir el daño causado por la isquemia-reperfusión en el músculo gastrocnemio de la rata.
- Published
- 2020
11. The effects of peripheral and central administration of hypericum perforatum L and the role of alpha-adernergic system
- Author
-
Khaksarian Mojtaba and Biranvand Fazaneh
- Subjects
Psychiatry ,RC435-571 - Published
- 2008
- Full Text
- View/download PDF
12. The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H2O2-induced oxidative stress in H9C2 cells.
- Author
-
Ghorbanzadeh, Vajihe, Jafarpour, Afsaneh, Pirnia, Afshin, Pajouhi, Naser, Khaksarian, Mojtaba, Veiskarami, Saeed, and Nazari, Afshin
- Subjects
OXYTOCIN receptors ,OXIDATIVE stress ,VASOPRESSIN ,CELL receptors ,CELL death ,WESTERN immunoblotting ,CELL survival - Abstract
Oxidative stress, has been shown to play an important role in the pathophysiology of cardiac remodelling and heart failure. The aim of study is effect of arginine vasopressin (AVP) on apoptosis of cardiomyocyte via its receptors. The cell viability effect of AVP in H9C2 cardiomyocytes was assayed using the MTT method. The transcription and translation level of apoptosis genes (Bax, Bcl-2, caspase-3) were discovered with qRT-PCR and western blotting. The results showed that vasopressin could reduce apoptosis in cardiomyocytes cell line through downregulation of caspase-3, BAX and upregulation of Bcl-2 (p <.001). Also, there was a decrease in anti-apoptosis effect of vasopressin when V1A and OTR receptors were blocked with their antagonists. These results suggest that activation of V1A and OTR receptors in H9C2 cells mediate protective effect of vasopressin via regulating apoptosis marker that lead to cell survival under conditions of stress oxidative. AVP may contribute to the improvement of heart ischaemia through its actions on V1A and OTR receptors. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Matricaria urea extract exhibits antinociceptive activity in male rat
- Author
-
Khaksarian Mojtaba
- Subjects
Psychiatry ,RC435-571 - Published
- 2006
- Full Text
- View/download PDF
14. Biosynthesis of titanium dioxide nanoparticles using Hypericum perforatum and Origanum vulgare extracts and their main components, hypericin and carvacrol as promising antibacterial agents.
- Author
-
Khaksarian, Mojtaba, Bahmani, Mahmoud, Taherikalani, Morovat, Ashrafi, Behnam, Rafieian-Kopaei, Mahmoud, and Abbasi, Naser
- Published
- 2022
- Full Text
- View/download PDF
15. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
- Author
-
Kinyoki, Damaris K., Ross, Jennifer M., Lazzar-Atwood, Alice, Munro, Sandra B., Schaeffer, Lauren E., Abbasalizad-Farhangi, Mahdieh, Abbasi, Masoumeh, Abbastabar, Hedayat, Abdelalim, Ahmed, Abdoli, Amir, Abdollahi, Mohammad, Abdollahpour, Ibrahim, Abdulkader, Rizwan Suliankatchi, Abebe, Nebiyu Dereje, Abebo, Teshome Abuka, Abegaz, Kedir Hussein, Abolhassani, Hassan, Abreu, Lucas Guimarães, Abrigo, Michael R. M., Abushouk, Abdelrahman I., Accrombessi, Manfred Mario Kokou, Acharya, Dilaram, Adabi, Maryam, Adebiyi, Akindele Olupelumi, Adedeji, Isaac Akinkunmi, Adekanmbi, Victor, Adeoye, Abiodun Moshood, Adetokunboh, Olatunji O., Adham, Davoud, Aduroja, Posi Emmanuel, Advani, Shailesh M., Afarideh, Mohsen, Aghaali, Mohammad, Agrawal, Anurag, Ahmad, Tauseef, Ahmadi, Keivan, Ahmadi, Sepideh, Ahmed, Muktar Beshir, Ahmed, Rushdia, Ajumobi, Olufemi, Akal, Chalachew Genet, Akalu, Temesgen Yihunie, Akinyemiju, Tomi, Akombi, Blessing, Al-Aly, Ziyad, Alam, Samiah, Alamene, Genet Melak, Alanzi, Turki M., Rabanal, Jacqueline Elizabeth Alcalde, Alema, Niguse Meles, Ali, Beriwan Abdulqadir, Ali, Muhammad, Alijanzadeh, Mehran, Alinia, Cyrus, Alipour, Vahid, Alizade, Hesam, Aljunid, Syed Mohamed, Almasi, Afshin, Almasi-Hashiani, Amir, Al-Mekhlafi, Hesham M., Al-Raddadi, Rajaa M., Altirkawi, Khalid, Alvis-Guzman, Nelson, Alvis-Zakzuk, Nelson J., Amare, Azmeraw T., Amegah, Adeladza Kofi, Amini, Saeed, Rarani, Mostafa Amini, Amiri, Fatemeh, Amit, Arianna Maever Loreche, Anber, Nahla Hamed, Andrei, Catalina Liliana, Ansari, Fereshteh, Ansari-Moghaddam, Alireza, Anteneh, Zelalem Alamrew, Antonio, Carl Abelardo T., Antriyandarti, Ernoiz, Anvari, Davood, Anwer, Razique, Appiah, Seth Christopher Yaw, Arabloo, Jalal, Arab-Zozani, Morteza, Araya, Ephrem Mebrahtu, Arefi, Zohreh, Aremu, Olatunde, Ärnlöv, Johan, Arzani, Afsaneh, Asadi-Aliabadi, Mehran, Asadi-Pooya, Ali A., Asgari, Samaneh, Asghari, Babak, Ashagre, Alebachew Fasil, Asrat, Anemaw A., Ataeinia, Bahar, Atalay, Hagos Tasew, Atnafu, Desta Debalkie, Atout, Maha Moh’d Wahbi, Ausloos, Marcel, Avokpaho, Euripide F. G. A., Awasthi, Ashish, Quintanilla, Beatriz Paulina Ayala, Ayanore, Martin Amogre, Aynalem, Yared A. Asmare, Azadmehr, Abbas, Azari, Samad, Azarian, Ghasem, Azene, Zelalem Nigussie, Babaee, Ebrahim, Badawi, Alaa, Badiye, Ashish D., Bahrami, Mohamad Amin, Baig, Atif Amin A., Bakhtiari, Ahad, Bakkannavar, Shankar M., Balakrishnan, Senthilkumar, Bali, Ayele Geleto, Banach, Maciej, Banik, Palash Chandra, Baradaran-Seyed, Zahra, Baraki, Adhanom Gebreegziabher, Barboza, Miguel A., Bärnighausen, Till Winfried, Barua, Lingkan, Basaleem, Huda, Basu, Sanjay, Bayati, Mohsen, Bayih, Mulat Tirfie, Baynes, Habtamu Wondifraw, Bedi, Neeraj, Behzadifar, Masoud, Behzadifar, Meysam, Bekele, Yibeltal Alemu, Bennett, Derrick A., Berbada, Dessalegn Ajema, Berhe, Kidanemaryam, Berhe, Abadi Kidanemariam, Berman, Adam E., Bernstein, Robert S., Bhageerathy, Reshmi, Bhandari, Dinesh, Bharadwaj, Pankaj, Bhattacharjee, Natalia V., Bhattacharyya, Krittika, Bijani, Ali, Bikbov, Boris, Bilano, Ver, Bililign, Nigus, Sayeed, Muhammad Shahdaat Bin, Birara, Setognal, Birhane, Minuye Biniam Biniam, Birhanu, Minyichil, Biswas, Raaj Kishore, Bitew, Zebenay Workneh, Bogale, Kassawmar Angaw, Bohlouli, Somayeh, Bolla, Srinivasa Rao, Boloor, Archith, Borzì, Antonio M., Borzouei, Shiva, Brady, Oliver J., Bragazzi, Nicola Luigi, Braithwaite, Dejana, Briko, Nikolay Ivanovich, Britton, Gabrielle, Budhathoki, Shyam S., Nagaraja, Sharath Burugina, Busse, Reinhard, Butt, Zahid A., Cahuana-Hurtado, Lucero, Cámera, Luis Alberto, Campos-Nonato, Ismael R., Cano, Jorge, Car, Josip, Cárdenas, Rosario, Carrero, Juan J., Carvalho, Félix, Castaldelli-Maia, João Mauricio, Castañeda-Orjuela, Carlos A., Castro, Franz, Cerin, Ester, Chansa, Collins, Charan, Jaykaran, Chatterjee, Pranab, Chattu, Vijay Kumar, Chauhan, Bal Govind, Chavshin, Ali Reza, Chehrazi, Mohammad, Chichiabellu, Tesfaye Yitna, Chin, Ken Lee, Christopher, Devasahayam J., Chu, Dinh-Toi, Cicuttini, Flavia M., Collison, Michael L., Cork, Michael A., Cormier, Natalie, Cortesi, Paolo Angelo, Costa, Vera M., Dadi, Abel Fekadu Fekadu, Dagnew, Baye, Dahlawi, Saad M. A., Damiani, Giovanni, Darwish, Amira Hamed, Daryani, Ahmad, Das, Jai K., Gupta, Rajat Das, Dávila-Cervantes, Claudio, Davis Weaver, Nicole, Leo, Diego De, Neve, Jan-Walter De, Demeke, Feleke Mekonnen, Demis, Asmamaw Bizuneh, Demissie, Dereje Bayissa, Demoz, Gebre Teklemariam, Denova-Gutiérrez, Edgar, Deribe, Kebede, Desai, Rupak, Desalegn, Beruk Berhanu, Desalew, Assefa, Deshpande, Aniruddha, Dey, Sagnik, Dharmaratne, Samath Dhamminda, Dhillon, Preeti, Dhimal, Meghnath, Dhungana, Govinda Prasad, Nasab, Mostafa Dianati, Diaz, Daniel, Forooshani, Zahra Sadat Dibaji, Dinsa, Girmaye Deye, Dipeolu, Isaac Oluwafemi, Djalalinia, Shirin, Do, Hoa Thi, Do, Huyen Phuc, Doku, Paul Narh, Dorostkar, Fariba, Doshmangir, Leila, Dubey, Manisha, Adema, Bereket Duko, Dunachie, Susanna J., Duncan, Bruce B., Cousin, Ewerton, Durães, Andre R., Earl, Lucas, Leylabadlo, Hamed Ebrahimzadeh, Eftekhari, Aziz, El Sayed, Iman, El Sayed Zaki, Maysaa, El Tantawi, Maha, Elbarazi, Iffat, Elemineh, Demelash Abewa, El-Jaafary, Shaimaa I., El-Khatib, Ziad, Elsharkawy, Aisha, El-Sherbiny, Yasser Mohamed, Elyazar, Iqbal R. F., Emamian, Mohammad Hassan, Enany, Shymaa, Endalew, Daniel Adane, Endalifer, Melese Linger, Eskandari, Khalil, Eskandarieh, Sharareh, Esmaeilnejad, Saman, Esteghamati, Alireza, Etemadi, Arash, Etisso, Atkilt Esaiyas, Fanzo, Jessica, Farahmand, Mohammad, Faraj, Anwar, Farashi, Sajjad, Fareed, Mohammad, Farioli, Andrea, Faro, Andre, Farzadfar, Farshad, Farzam, Hossein, Fatima, Syeda Sadia, Fattahi, Nazir, Fauk, Nelsensius Klau, Fazaeli, Ali Akbar, Fentahun, Netsanet, Ferede, Tomas Y., Fereshtehnejad, Seyed-Mohammad, Fernandes, Eduarda, Fernandes, João C., Feyissa, Garumma Tolu, Filip, Irina, Fischer, Florian, Flohr, Carsten, Foigt, Nataliya A., Folayan, Morenike Oluwatoyin, Fomenkov, Artem Alekseevich, Foroutan, Masoud, Förster, Jana, Francis, Joel Msafiri, Fukumoto, Takeshi, Gayesa, Reta Tsegaye, Geberemariyam, Biniyam Sahiledengle, Gebrehiwot, Tsegaye Tewelde, Gebremariam, Hadush, Gebremariam, Kidane Tadesse, Gebremedhin, Ketema Bizuwork Bizuwork, Gebremeskel, Gebreamlak Gebremedhn, Gebreslassie, Assefa Ayalew Ayalew, Gebretsadik, Gebretsadkan G. G., Gedefaw, Getnet Azeze, Geramo, Yilma Chisha Dea, Gesesew, Hailay Abrha, Geta, Birhanu, Getenet, Agegnehu Bante, Gezae, Kebede Embaye, Ghaffarifar, Fatemeh, Ghafourifard, Mansour, Ghajar, Alireza, Ghajarzadeh, Mahsa, Ghashghaee, Ahmad, Ghiasvand, Hesam, Gholamian, Asadollah, Gilani, Syed Amir, Gill, Tiffany K., Ginawi, Ibrahim Abdelmageed, Goli, Srinivas, Gomes, Nelson G. M., Gopalani, Sameer Vali, Goudarzi, Houman, Goulart, Alessandra C., Govindakarnavar, Arunkumar, Grada, Ayman, Grivna, Michal, Guimarães, Rafael Alves, Guled, Rashid Abdi, Guo, Yuming, Gupta, Rahul, Gupta, Rajeev, Hafezi-Nejad, Nima, Haile, Michael Tamene, Haj-Mirzaian, Arvin, Haj-Mirzaian, Arya, Hall, Brian J., Halvaei, Iman, Hamadeh, Randah R., Hamidi, Yadollah, Handiso, Demelash Woldeyohannes, Hankey, Graeme J., Haririan, Hamidreza, Hariyani, Ninuk, Hasaballah, Ahmed I., Hasan, Md. Mehedi, Hasankhani, Milad, Hasanpoor, Edris, Hasanzadeh, Amir, Hashemian, Maryam, Hassanipour, Soheil, Hassen, Hamid Yimam, Havmoeller, Rasmus, Hawkes, Corinna, Hayat, Khezar, Hayelom, Desta Haftu, Heidari, Behnam, Heidari-Soureshjani, Reza, Hendrie, Delia, Henok, Andualem, Henry, Nathaniel J., Herrero, Mario, Herteliu, Claudiu, Heydarpour, Fatemeh, de Hidru, Hagos D., Hoang, Chi Linh, Hoek, Hans W., Hole, Michael K., Holla, Ramesh, Hollerich, Gillian, Rad, Enayatollah Homaie, Hong, Sung Hwi, Hoogar, Praveen, Horino, Masako, Hossain, Naznin, Hosseini, Mostafa, Hosseinzadeh, Mehdi, Hostiuc, Mihaela, Hostiuc, Sorin, Househ, Mowafa, Hsairi, Mohamed, Hu, Guoqing, Huda, Tanvir M., Humayun, Ayesha, Hwang, Bing-Fang, Ibitoye, Segun Emmanuel, Ilesanmi, Olayinka Stephen, Ilic, Milena D., Imani-Nasab, Mohammad Hasan, Inbaraj, Leeberk Raja, Iqbal, Usman, Irvani, Seyed Sina Naghibi, Islam, Sheikh Mohammed Shariful, Iwu, Chidozie C. D., Iwu, Chinwe Juliana, Izadi, Neda, Jaafari, Jalil, Jaca, Anelisa, Jadidi-Niaragh, Farhad, Balalami, Nader Jafari, Jafarinia, Morteza, Jahani, Mohammad Ali, Jakovljevic, Mihajlo, Jalali, Amir, Jalilian, Farzad, Jayatilleke, Achala Upendra, Jeemon, Panniyammakal, Jehan, Fyezah, Jenabi, Ensiyeh, Jha, Ravi Prakash, Jha, Vivekanand, Ji, John S., Jia, Peng, John, Oommen, John-Akinola, Yetunde O., Johnson, Kimberly B., Jonas, Jost B., Joseph, Nitin, Joukar, Farahnaz, Jozwiak, Jacek Jerzy, Jungari, Suresh Banayya, Jürisson, Mikk, Kabir, Ali, Kabir, Zubair, Kahsay, Amaha, Kahssay, Molla, Kalani, Hamed, Kalankesh, Leila L., Kalhor, Rohollah, Kamiab, Zahra, Kanchan, Tanuj, Kapil, Umesh, Kapoor, Neeti, Karami, Manoochehr, Matin, Behzad Karami, Karch, André, Karim, Mohd A., Karki, Surendra, Kasaeian, Amir, Kasahun, Gebremicheal Gebreslassie, Kasaye, Habtamu Kebebe, Kassa, Tesfaye Dessale, Kassaye, Hagazi Gebremedhin, Kassebaum, Nicholas J., Karyani, Ali Kazemi, Kengne, Andre Pascal, Ketema, Daniel Bekele, Khader, Yousef Saleh, Khafaie, Morteza Abdullatif, Khaksarian, Mojtaba, Khalid, Nauman, Khalil, Ibrahim A., Khalilov, Rovshan, Khan, Asad, Khan, Ejaz Ahmad, Khan, Md Nuruzzaman, Khan, Mohammad Saud, Khan, Muhammad Shahzeb, Khatab, Khaled, Khater, Amir, Khater, Mona M., Khatib, Mahalqua Nazli, Khayamzadeh, Maryam, Khazaei-Pool, Maryam, Khazaei, Mohammad, Khazaei, Salman, Khodayari, Mohammad Taghi, Khosravi, Mohammad Hossein, Khundkar, Roba, Kiadaliri, Ali, Kianipour, Neda, Kiirithio, Daniel N., Kim, Yun Jin, Kimokoti, Ruth W., Kisa, Adnan, Kisa, Sezer, Kolola, Tufa, Komaki, Hamidreza, Kondlahalli, Shivakumar K. M., Koolivand, Ali, Koul, Parvaiz A., Koyanagi, Ai, Kraemer, Moritz U. G., Krishan, Kewal, Krohn, Kris J., Kugbey, Nuworza, Kumar, Manasi, Kumar, Pushpendra, Kumar, Vivek, Kurmi, Om P., Kuti, Oluwatosin, Vecchia, Carlo La, Lacey, Ben, Lad, Deepesh P., Lal, Aparna, Lal, Dharmesh Kumar, Lami, Faris Hasan, Lamichhane, Prabhat, Lang, Justin J., Lansingh, Van C., Lasrado, Savita, Lebedev, Georgy, Lee, Paul H., Lee, Shaun Wen Huey, Leili, Mostafa, Letourneau, Ian D., Lewycka, Sonia, Li, Shanshan, Lim, Lee-Ling, Linn, Shai, Liu, Shiwei, Liu, Simin, Lodha, Rakesh, Longbottom, Joshua, Lopez, Jaifred Christian F., Lorkowski, Stefan, Macarayan, Erlyn Rachelle King, Madadin, Mohammed, El Razek, Hassan Magdy Abd, El Razek, Muhammed Magdy Abd, Maghavani, Dhaval P., Mahasha, Phetole Walter, Mahotra, Narayan Bahadur, Maled, Venkatesh, Maleki, Afshin, Maleki, Shokofeh, Malta, Deborah Carvalho, Manafi, Ali, Manafi, Farzad, Manafi, Navid, Manohar, Narendar Dawanu, Mansour-Ghanaei, Fariborz, Mansouri, Borhan, Mansournia, Mohammad Ali, Mapoma, Chabila Christopher, Marami, Dadi, Marczak, Laurie B., Arnedo, Carlos Alberto Marrugo, Martins-Melo, Francisco Rogerlândio, Masaka, Anthony, Massenburg, Benjamin Ballard, Maulik, Pallab K., Mayala, Benjamin K., Mazidi, Mohsen, Mehndiratta, Man Mohan, Mehri, Freshteh, Mehta, Kala M., Meitei, Wahengbam Bigyananda, Mekonnen, Fantahun Ayenew, Mekonnen, Teferi, Meles, Gebrekiros Gebremichael, Meles, Hagazi Gebre, Melese, Addisu, Mendoza, Walter, Menezes, Ritesh G., Mengesha, Meresa Berwo, Mensah, George A., Meretoja, Tuomo J., Miazgowski, Tomasz, Kostova, Neda Milevska, Miller, Ted R., Mills, Edward J., Mini, G. K., Mir, Seyed Mostafa, Miri, Mohammad, Mirjalali, Hamed, Mirrakhimov, Erkin M., Mirzaei, Hamed, Mirzaei, Maryam, Mirzaei, Roya, Mirzaei-Alavijeh, Mehdi, Mithra, Prasanna, Moazen, Babak, Mohamadi, Efat, Mohamadi-Bolbanabad, Amjad, Mohammad, Karzan Abdulmuhsin, Mohammad, Yousef, Mohammad, Dara K., Darwesh, Aso Mohammad, Mezerji, Naser Mohammad Gholi, Mohammadian-Hafshejani, Abdollah, Mohammadnia-Afrouzi, Mousa, Mohammadoo-Khorasani, Milad, Mohammadpourhodki, Reza, Mohammed, Salahuddin, Mohammed, Shafiu, Mohammed, Jemal Abdu, Mohammed, Ammas Siraj, Mohebi, Farnam, Mokari, Amin, Mokdad, Ali H., Montañez, Julio Cesar, Montero-Zamora, Pablo A., Moodley, Yoshan, Moossavi, Maryam, Moradi, Ghobad, Moradi, Masoud, Moradi, Yousef, Moradi-Joo, Mohammad, Moradi-Lakeh, Maziar, Moradpour, Farhad, Moradzadeh, Rahmatollah, Moraga, Paula, Morrison, Shane Douglas, Mosapour, Abbas, Mosser, Jonathan F., Mouodi, Simin, Khaneghah, Amin Mousavi, Mozaffarian, Dariush, Mueller, Ulrich Otto, Murray, Christopher J. L., Murthy, G. V. S., Musa, Kamarul Imran, Mustafa, Ghulam, Muthupandian, Saravanan, Nabavizadeh, Behnam, Naderi, Mehdi, Nadkarni, Girish N., Nagarajan, Ahamarshan Jayaraman, Naghavi, Mohsen, Naheed, Aliya, Naik, Gurudatta, Najafi, Farid, Nansseu, Jobert Richie, Narayan, K. M. Venkat, Nascimento, Bruno Ramos, Nayak, Vinod, Nazari, Javad, Ndwandwe, Duduzile Edith, Negoi, Ionut, Negoi, Ruxandra Irina, Ngunjiri, Josephine W., Nguyen, Cuong Tat, Nguyen, Huong Lan Thi, Nigatu, Dabere, Nigatu, Yeshambel T., Nikbakhsh, Rajan, Ningrum, Dina Nur Anggraini, Nnaji, Chukwudi A., Nong, Vuong Minh, Noubiap, Jean Jacques, Nowak, Christoph, Oancea, Bogdan, Ofori-Asenso, Richard, Oghenetega, Onome Bright, Oh, In-Hwan, Oladimeji, Olanrewaju, Oladnabi, Morteza, Olagunju, Andrew T., Olagunju, Tinuke O., Olusanya, Bolajoko Olubukunola, Olusanya, Jacob Olusegun, Oluwasanu, Mojisola Morenike, Omer, Muktar Omer, Onwujekwe, Obinna E., Asante, Kwaku Oppong, Oren, Eyal, Orisakwe, Orish Ebere, Ortiz, Alberto, Osarenotor, Osayomwanbo, Osgood-Zimmerman, Aaron E., Owolabi, Mayowa Ojo, P. A., Mahesh, Padubidri, Jagadish Rao, Pakshir, Keyvan, Pana, Adrian, Panda-Jonas, Songhomitra, Parsian, Hadi, Pashaei, Tahereh, Pasupula, Deepak Kumar, Patel, Sangram Kishor, Pathak, Ashish, Pathak, Mona, Pati, Sanghamitra, Patle, Ajay, Patton, George C., Paulos, Kebreab, Toroudi, Hamidreza Pazoki, Pepito, Veincent Christian Filipino, Perico, Norberto, Petri, William A., Pickering, Brandon V., Pigott, David M., Pirestani, Majid, Piroozi, Bakhtiar, Pirsaheb, Meghdad, Pokhrel, Khem Narayan, Postma, Maarten J., Pourjafar, Hadi, Pourmalek, Farshad, Kalhori, Reza Pourmirza, Pourshams, Akram, Poustchi, Hossein, Prada, Sergio I., Preotescu, Liliana, Pribadi, Dimas Ria Angga, Syed, Zahiruddin Quazi, Rabiee, Mohammad, Rabiee, Navid, Radfar, Amir, Rafiei, Alireza, Rahim, Fakher, Rahimi-Movaghar, Vafa, Rahman, Muhammad Aziz, Rahman, Sajjad ur, Rai, Rajesh Kumar, Rajabpour-Sanati, Ali, Rajati, Fatemeh, Ramezanzadeh, Kiana, Rana, Saleem Muhammad, Ranabhat, Chhabi Lal, Rao, Sowmya J., Rasella, Davide, Rashedi, Vahid, Rastogi, Prateek, Rathi, Priya, Rawaf, Salman, Rawaf, David Laith, Rawal, Lal, Ray, Sarah E., Remuzzi, Giuseppe, Renjith, Vishnu, Renzaho, Andre M. N., Resnikoff, Serge, Rezaei, Nima, Rezaeian, Shahab, Rezai, Mohammad Sadegh, Rezapour, Aziz, Riahi, Seyed Mohammad, Ribeiro, Ana Isabel, Rickard, Jennifer, Rodriguez, Alina, Roever, Leonardo, Roro, Elias Merdassa, Roshandel, Gholamreza, Rostami, Ali, Rubagotti, Enrico, Saad, Anas M., Saadatagah, Seyedmohammad, Sabde, Yogesh Damodar, Sabour, Siamak, Sadeghi, Ehsan, Sadeghi, Masoumeh, Safari, Saeed, Safari, Yahya, Safarpour, Hamid, Sagar, Rajesh, Sahebkar, Amirhossein, Sahraian, Mohammad Ali, Sajadi, S. Mohammad, Salahshoor, Mohammad Reza, Salam, Nasir, Salehi, Farkhonde, Zahabi, Saleh Salehi, Salem, Hosni, Salem, Marwa R. Rashad, Salimi, Yahya, Salimzadeh, Hamideh, Kafil, Hossein Samadi, Sambala, Evanson Zondani, Samy, Abdallah M., Santos, Itamar S., Jose, Bruno Piassi Sao, Saraswathy, Sivan Yegnanarayana Iyer, Sarker, Abdur Razzaque, Sartorius, Benn, Sarveazad, Arash, Sathian, Brijesh, Satpathy, Maheswar, Saxena, Sonia, Sayyah, Mehdi, Sbarra, Alyssa N., Schipp, Megan F., Schmidt, Maria Inês, Schutte, Aletta Elisabeth, Schwebel, David C., Senbeta, Anbissa Muleta, Senthilkumaran, Subramanian, Seyedmousavi, Seyedmojtaba, Shaahmadi, Faramarz, Shafaat, Omid, Shahabi, Saeed, Shaikh, Masood Ali, Shalash, Ali S., Shams-Beyranvand, Mehran, Shamshirian, Amir, Shamsizadeh, Morteza, Shannawaz, Mohammed, Sharafi, Kiomars, Sharif, Mehdi, Sharma, Rajesh, Shehata, Hatem Samir, Sheikhtaheri, Abbas, Shibuya, Kenji, Shiferaw, Wondimeneh Shibabaw, Shigematsu, Mika, Shin, Jae Il, Shiri, Rahman, Shirkoohi, Reza, Shiue, Ivy, Shuval, Kerem, Siabani, Soraya, Siddiqi, Tariq J., Sigfusdottir, Inga Dora, Silva, Diego Augusto Santos, Simonetti, Biagio, Singh, Ambrish, Singh, Pushpendra, Singh, Virendra, Singh, Jasvinder A., Singh, Pankaj Kumar, Sinha, Dhirendra Narain, Sintayehu, Yitagesu, Sisay, Malede Mequanent M., Soheili, Amin, Soleymani, Bija, Soltani, Farzaneh, Soltani, Shahin, Soriano, Joan B., Sorrie, Muluken Bekele, Soshnikov, Sergey, Soyiri, Ireneous N., Spotin, Adel, Sreeramareddy, Chandrashekhar T., Srivastava, Rajni Kant Kant, Starodubova, Antonina, Sudaryanto, Agus, Sufiyan, Mu’awiyyah Babale, Suleria, Hafiz Ansar Rasul, Sulo, Gerhard, Sunguya, Bruno F., Sykes, Bryan L., Tabarés-Seisdedos, Rafael, Tabuchi, Takahiro, Tadesse, Birkneh Tilahun, Taherkhani, Amir, Tamirat, Koku Sisay, Tassew, Segen Gebremeskel, Taveira, Nuno, Teklehaimanot, Berhane Fseha, Tekulu, Gebretsadkan Hintsa, Temsah, Mohamad-Hani, Terkawi, Abdullah Sulieman, Tessema, Zemenu Tadesse, Thomas, Nihal, Titova, Mariya Vladimirovna, Tlaye, Kenean Getaneh, Tohidinik, Hamid Reza, Tonelli, Marcello, Tovani-Palone, Marcos Roberto, Traini, Eugenio, Tran, Khanh Bao, Tripathi, Manjari, Uddin, Riaz, Ullah, Irfan, Unnikrishnan, Bhaskaran, Upadhyay, Era, Useh, Ushotanefe, Usman, Muhammad Shariq, Uthman, Olalekan A., Vacante, Marco, Vaezghasemi, Masoud, Valdez, Pascual R., VanderHeide, John, Varavikova, Elena, Varughese, Santosh, Vasankari, Tommi Juhani, Vasseghian, Yasser, Veisani, Yousef, Venkatesh, Srinivasaraghavan, Venketasubramanian, Narayanaswamy, Verma, Madhur, Vidale, Simone, Violante, Francesco S., Vlassov, Vasily, Vollmer, Sebastian, Vukovic, Rade, Waheed, Yasir, Wang, Haidong, Wang, Yafeng, Wang, Yuan-Pang, Weldesamuel, Girmay Teklay, Werdecker, Andrea, Wiangkham, Taweewat, Wiens, Kirsten E., Wijeratne, Tissa, Wolde, Haileab Fekadu, Wondafrash, Dawit Zewdu, Wonde, Tewodros Eshete, Wondmieneh, Adam Belay, Wu, Ai-Min, Xu, Gelin, Yadegar, Abbas, Yadollahpour, Ali, Jabbari, Seyed Hossein Yahyazadeh, Yamada, Tomohide, Yano, Yuichiro, Yaya, Sanni, Yazdi-Feyzabadi, Vahid, Yeshaneh, Alex, Yeshaw, Yigizie, Yeshitila, Yordanos Gizachew, Yilma, Mekdes Tigistu, Yip, Paul, Yonemoto, Naohiro, Yoon, Seok-Jun, Youm, Yoosik, Younis, Mustafa Z., Yousefi, Zabihollah, Yousof, Hebat-Allah Salah A., Yu, Chuanhua, Yusefzadeh, Hasan, Moghadam, Telma Zahirian, Zaki, Leila, Zaman, Sojib Bin, Zamani, Mohammad, Zamanian, Maryam, Zandian, Hamed, Zarafshan, Hadi, Zepro, Nejimu Biza, Zerfu, Taddese Alemu, Zewale, Taye Abuhay, Zhang, Yunquan, Zhang, Zhi-Jiang, Zhao, Xiu-Ju, Zodpey, Sanjay, Zomorodian, Kamiar, Zotor, Francis Bruno, Afshin, Ashkan, Hay, Simon I., LBD Double Burden of Malnutrition Collaborator, Violante FS, Adema, Bereket Duko, Yeshaw, Yigizie, LBD Double Burden of Malnutrition Collaborators, Instituto de Saúde Pública da Universidade do Porto, 10922180 - Schutte, Aletta Elisabeth, UAM. Departamento de Medicina, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-IP), Veritati - Repositório Institucional da Universidade Católica Portuguesa, Biosciences, University of Helsinki, Clinicum, HUS Comprehensive Cancer Center, Institute for Molecular Medicine Finland, Department of Earth Observation Science, UT-I-ITC-ACQUAL, Faculty of Geo-Information Science and Earth Observation, Sálfræðideild (HR), Department of Psychology (RU), Samfélagssvið (HR), School of Social Sciences (RU), Háskólinn í Reykjavík, Reykjavik University, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (ISS-FJD), Kinyoki, D, Ross, J, Lazzar-Atwood, A, Munro, S, Schaeffer, L, Abbasalizad-Farhangi, M, Abbasi, M, Abbastabar, H, Abdelalim, A, Abdoli, A, Abdollahi, M, Abdollahpour, I, Abdulkader, R, Abebe, N, Abebo, T, Abegaz, K, Abolhassani, H, Abreu, L, Abrigo, M, Abushouk, A, Accrombessi, M, Acharya, D, Adabi, M, Adebiyi, A, Adedeji, I, Adekanmbi, V, Adeoye, A, Adetokunboh, O, Adham, D, Aduroja, P, Advani, S, Afarideh, M, Aghaali, M, Agrawal, A, Ahmad, T, Ahmadi, K, Ahmadi, S, Ahmed, M, Ahmed, R, Ajumobi, O, Akal, C, Akalu, T, Akinyemiju, T, Akombi, B, Al-Aly, Z, Alam, S, Alamene, G, Alanzi, T, Rabanal, J, Alema, N, Ali, B, Ali, M, Alijanzadeh, M, Alinia, C, Alipour, V, Alizade, H, Aljunid, S, Almasi, A, Almasi-Hashiani, A, Al-Mekhlafi, H, Al-Raddadi, R, Altirkawi, K, Alvis-Guzman, N, Alvis-Zakzuk, N, Amare, A, Amegah, A, Amini, S, Rarani, M, Amiri, F, Amit, A, Anber, N, Andrei, C, Ansari, F, Ansari-Moghaddam, A, Anteneh, Z, Antonio, C, Antriyandarti, E, Anvari, D, Anwer, R, Appiah, S, Arabloo, J, Arab-Zozani, M, Araya, E, Arefi, Z, Aremu, O, Arnlov, J, Arzani, A, Asadi-Aliabadi, M, Asadi-Pooya, A, Asgari, S, Asghari, B, Ashagre, A, Asrat, A, Ataeinia, B, Atalay, H, Atnafu, D, Atout, M, Ausloos, M, Avokpaho, E, Awasthi, A, Quintanilla, B, Ayanore, M, Aynalem, Y, Azadmehr, A, Azari, S, Azarian, G, Azene, Z, Babaee, E, Badawi, A, Badiye, A, Bahrami, M, Baig, A, Bakhtiari, A, Bakkannavar, S, Balakrishnan, S, Bali, A, Banach, M, Banik, P, Baradaran-Seyed, Z, Baraki, A, Barboza, M, Barnighausen, T, Barua, L, Basaleem, H, Basu, S, Bayati, M, Bayih, M, Baynes, H, Bedi, N, Behzadifar, M, Bekele, Y, Bennett, D, Berbada, D, Berhe, K, Berhe, A, Berman, A, Bernstein, R, Bhageerathy, R, Bhandari, D, Bharadwaj, P, Bhattacharjee, N, Bhattacharyya, K, Bijani, A, Bikbov, B, Bilano, V, Bililign, N, Sayeed, M, Birara, S, Birhane, M, Birhanu, M, Biswas, R, Bitew, Z, Bogale, K, Bohlouli, S, Bolla, S, Boloor, A, Borzi, A, Borzouei, S, Brady, O, Bragazzi, N, Braithwaite, D, Briko, N, Britton, G, Budhathoki, S, Nagaraja, S, Busse, R, Butt, Z, Cahuana-Hurtado, L, Camera, L, Campos-Nonato, I, Cano, J, Car, J, Cardenas, R, Carrero, J, Carvalho, F, Castaldelli-Maia, J, Castaneda-Orjuela, C, Castro, F, Cerin, E, Chansa, C, Charan, J, Chatterjee, P, Chattu, V, Chauhan, B, Chavshin, A, Chehrazi, M, Chichiabellu, T, Chin, K, Christopher, D, Chu, D, Cicuttini, F, Collison, M, Cork, M, Cormier, N, Cortesi, P, Costa, V, Dadi, A, Dagnew, B, Dahlawi, S, Damiani, G, Darwish, A, Daryani, A, Das, J, Gupta, R, Davila-Cervantes, C, Davis Weaver, N, Leo, D, Neve, J, Demeke, F, Demis, A, Demissie, D, Demoz, G, Denova-Gutierrez, E, Deribe, K, Desai, R, Desalegn, B, Desalew, A, Deshpande, A, Dey, S, Dharmaratne, S, Dhillon, P, Dhimal, M, Dhungana, G, Nasab, M, Diaz, D, Forooshani, Z, Dinsa, G, Dipeolu, I, Djalalinia, S, Do, H, Doku, P, Dorostkar, F, Doshmangir, L, Dubey, M, Adema, B, Dunachie, S, Duncan, B, Duraes, A, Earl, L, Leylabadlo, H, Eftekhari, A, El Sayed, I, El Sayed Zaki, M, El Tantawi, M, Elbarazi, I, Elemineh, D, El-Jaafary, S, El-Khatib, Z, Elsharkawy, A, El-Sherbiny, Y, Elyazar, I, Emamian, M, Enany, S, Endalew, D, Endalifer, M, Eskandari, K, Eskandarieh, S, Esmaeilnejad, S, Esteghamati, A, Etemadi, A, Etisso, A, Fanzo, J, Farahmand, M, Faraj, A, Farashi, S, Fareed, M, Farioli, A, Faro, A, Farzadfar, F, Farzam, H, Fatima, S, Fattahi, N, Fauk, N, Fazaeli, A, Fentahun, N, Ferede, T, Fereshtehnejad, S, Fernandes, E, Fernandes, J, Feyissa, G, Filip, I, Fischer, F, Flohr, C, Foigt, N, Folayan, M, Fomenkov, A, Foroutan, M, Forster, J, Francis, J, Fukumoto, T, Gayesa, R, Geberemariyam, B, Gebrehiwot, T, Gebremariam, H, Gebremariam, K, Gebremedhin, K, Gebremeskel, G, Gebreslassie, A, Gebretsadik, G, Gedefaw, G, Geramo, Y, Gesesew, H, Geta, B, Getenet, A, Gezae, K, Ghaffarifar, F, Ghafourifard, M, Ghajar, A, Ghajarzadeh, M, Ghashghaee, A, Ghiasvand, H, Gholamian, A, Gilani, S, Gill, T, Ginawi, I, Goli, S, Gomes, N, Gopalani, S, Goudarzi, H, Goulart, A, Govindakarnavar, A, Grada, A, Grivna, M, Guimaraes, R, Guled, R, Guo, Y, Hafezi-Nejad, N, Haile, M, Haj-Mirzaian, A, Hall, B, Halvaei, I, Hamadeh, R, Hamidi, Y, Handiso, D, Hankey, G, Haririan, H, Hariyani, N, Hasaballah, A, Hasan, M, Hasankhani, M, Hasanpoor, E, Hasanzadeh, A, Hashemian, M, Hassanipour, S, Hassen, H, Havmoeller, R, Hawkes, C, Hayat, K, Hayelom, D, Heidari, B, Heidari-Soureshjani, R, Hendrie, D, Henok, A, Henry, N, Herrero, M, Herteliu, C, Heydarpour, F, de Hidru, H, Hoang, C, Hoek, H, Hole, M, Holla, R, Hollerich, G, Rad, E, Hong, S, Hoogar, P, Horino, M, Hossain, N, Hosseini, M, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Housseh, M, Hsairi, M, Hu, G, Huda, T, Humayun, A, Hwang, B, Ibitoye, S, Ilesanmi, O, Ilic, M, Imani-Nasab, M, Inbaraj, L, Iqbal, U, Irvani, S, Islam, S, Iwu, C, Izadi, N, Jaafari, J, Jaca, A, Jadidi-Niaragh, F, Balalami, N, Jafarinia, M, Jahani, M, Jakovljevic, M, Jalali, A, Jalilian, F, Jayatilleke, A, Jeemon, P, Jehan, F, Jenabi, E, Jha, R, Jha, V, Ji, J, Jia, P, John, O, John-Akinola, Y, Johnson, K, Jonas, J, Joseph, N, Joukar, F, Jozwiak, J, Jungari, S, Jurisson, M, Kabir, A, Kabir, Z, Kahsay, A, Kahssay, M, Kalani, H, Kalankesh, L, Kalhor, R, Kamiab, Z, Kanchan, T, Kapil, U, Kapoor, N, Karami, M, Matin, B, Karch, A, Karim, M, Karki, S, Kasaeian, A, Kasahun, G, Kasaye, H, Kassa, T, Kassaye, H, Kassebaum, N, Karyani, A, Kengne, A, Ketema, D, Khader, Y, Khafaie, M, Khaksarian, M, Khalid, N, Khalil, I, Khalilov, R, Khan, A, Khan, E, Khan, M, Khatab, K, Khater, A, Khater, M, Khatib, M, Khayamzadeh, M, Khazaei-Pool, M, Khazaei, M, Khazaei, S, Khodayari, M, Khosravi, M, Khundkar, R, Kiadaliri, A, Kianipour, N, Kiirithio, D, Kim, Y, Kimokoti, R, Kisa, A, Kisa, S, Kolola, T, Komaki, H, Kondlahalli, S, Koolivand, A, Koul, P, Koyanagi, A, Kraemer, M, Krishan, K, Krohn, K, Kugbey, N, Kumar, M, Kumar, P, Kumar, V, Kurmi, O, Kuti, O, Vecchia, C, Lacey, B, Lad, D, Lal, A, Lal, D, Lami, F, Lamichhane, P, Lang, J, Lansingh, V, Lasrado, S, Lebedev, G, Lee, P, Lee, S, Leili, M, Letourneau, I, Lewycka, S, Li, S, Lim, L, Linn, S, Liu, S, Lodha, R, Longbottom, J, Lopez, J, Lorkowski, S, Macarayan, E, Madadin, M, El Razek, H, El Razek, M, Maghavani, D, Mahasha, P, Mahotra, N, Maled, V, Maleki, A, Maleki, S, Malta, D, Manafi, A, Manafi, F, Manafi, N, Manohar, N, Mansour-Ghanaei, F, Mansouri, B, Mansournia, M, Mapoma, C, Marami, D, Marczak, L, Arnedo, C, Martins-Melo, F, Masaka, A, Massenburg, B, Maulik, P, Mayala, B, Mazidi, M, Mehndiratta, M, Mehri, F, Mehta, K, Meitei, W, Mekonnen, F, Mekonnen, T, Meles, G, Meles, H, Melese, A, Mendoza, W, Menezes, R, Mengesha, M, Mensah, G, Meretoja, T, Miazgowski, T, Kostova, N, Miller, T, Mills, E, Mini, G, Mir, S, Miri, M, Mirjalali, H, Mirrakhimov, E, Mirzaei, H, Mirzaei, M, Mirzaei, R, Mirzaei-Alavijeh, M, Mithra, P, Moazen, B, Mohamadi, E, Mohamadi-Bolbanabad, A, Mohammad, K, Mohammad, Y, Mohammad, D, Darwesh, A, Mezerji, N, Mohammadian-Hafshejani, A, Mohammadnia-Afrouzi, M, Mohammadoo-Khorasani, M, Mohammadpourhodki, R, Mohammed, S, Mohammed, J, Mohammed, A, Mohebi, F, Mokari, A, Mokdad, A, Montanez, J, Montero-Zamora, P, Moodley, Y, Moossavi, M, Moradi, G, Moradi, M, Moradi, Y, Moradi-Joo, M, Moradi-Lakeh, M, Moradpour, F, Moradzadeh, R, Moraga, P, Morrison, S, Mosapour, A, Mosser, J, Mouodi, S, Khaneghah, A, Mozaffarian, D, Mueller, U, Murray, C, Murthy, G, Musa, K, Mustafa, G, Muthupandian, S, Nabavizadeh, B, Naderi, M, Nadkarni, G, Nagarajan, A, Naghavi, M, Naheed, A, Naik, G, Najafi, F, Nansseu, J, Narayan, K, Nascimento, B, Nayak, V, Nazari, J, Ndwandwe, D, Negoi, I, Negoi, R, Ngunjiri, J, Nguyen, C, Nguyen, H, Nigatu, D, Nigatu, Y, Nikbakhsh, R, Ningrum, D, Nnaji, C, Nong, V, Noubiap, J, Nowak, C, Oancea, B, Ofori-Asenso, R, Oghenetega, O, Oh, I, Oladimeji, O, Oladnabi, M, Olagunju, A, Olagunju, T, Olusanya, B, Olusanya, J, Oluwasanu, M, Omer, M, Onwujekwe, O, Asante, K, Oren, E, Orisakwe, O, Ortiz, A, Osarenotor, O, Osgood-Zimmerman, A, Owolabi, M, P. A, M, Padubidri, J, Pakshir, K, Pana, A, Panda-Jonas, S, Parsian, H, Pashaei, T, Pasupula, D, Patel, S, Pathak, A, Pathak, M, Pati, S, Patle, A, Patton, G, Paulos, K, Toroudi, H, Pepito, V, Perico, N, Petri, W, Pickering, B, Pigott, D, Pirestani, M, Piroozi, B, Pirsaheb, M, Pokhrel, K, Postma, M, Pourjafar, H, Pourmalek, F, Kalhori, R, Pourshams, A, Poustchi, H, Prada, S, Preotescu, L, Pribadi, D, Syed, Z, Rabiee, M, Rabiee, N, Radfar, A, Rafiei, A, Rahim, F, Rahimi-Movaghar, V, Rahman, M, Rahman, S, Rai, R, Rajabpour-Sanati, A, Rajati, F, Ramezanzadeh, K, Rana, S, Ranabhat, C, Rao, S, Rasella, D, Rashedi, V, Rastogi, P, Rathi, P, Rawaf, S, Rawaf, D, Rawal, L, Ray, S, Remuzzi, G, Renjith, V, Renzaho, A, Resnikoff, S, Rezaei, N, Rezaeian, S, Rezai, M, Rezapour, A, Riahi, S, Ribeiro, A, Rickard, J, Rodriguez, A, Roever, L, Roro, E, Roshandel, G, Rostami, A, Rubagotti, E, Saad, A, Saadatagah, S, Sabde, Y, Sabour, S, Sadeghi, E, Sadeghi, M, Safari, S, Safari, Y, Safarpour, H, Sagar, R, Sahebkar, A, Sahraian, M, Sajadi, S, Salahshoor, M, Salam, N, Salehi, F, Zahabi, S, Salem, H, Salem, M, Salimi, Y, Salimzadeh, H, Kafil, H, Sambala, E, Samy, A, Santos, I, Jose, B, Saraswathy, S, Sarker, A, Sartorius, B, Sarveazad, A, Sathian, B, Satpathy, M, Saxena, S, Sayyah, M, Sbarra, A, Schipp, M, Schmidt, M, Schutte, A, Schwebel, D, Senbeta, A, Senthilkumaran, S, Seyedmousavi, S, Shaahmadi, F, Shafaat, O, Shahabi, S, Shaikh, M, Shalash, A, Shams-Beyranvand, M, Shamshirian, A, Shamsizadeh, M, Shannawaz, M, Sharafi, K, Sharif, M, Sharma, R, Shehata, H, Sheikhtaheri, A, Shibuya, K, Shiferaw, W, Shigematsu, M, Shin, J, Shiri, R, Shirkoohi, R, Shiue, I, Shuval, K, Siabani, S, Siddiqi, T, Sigfusdottir, I, Silva, D, Simonetti, B, Singh, A, Singh, P, Singh, V, Singh, J, Sinha, D, Sintayehu, Y, Sisay, M, Soheili, A, Soleymani, B, Soltani, F, Soltani, S, Soriano, J, Sorrie, M, Soshnikov, S, Soyiri, I, Spotin, A, Sreeramareddy, C, Srivastava, R, Starodubova, A, Sudaryanto, A, Sufiyan, M, Suleria, H, Sulo, G, Sunguya, B, Sykes, B, Tabares-Seisdedos, R, Tabuchi, T, Tadesse, B, Taherkhani, A, Tamirat, K, Tassew, S, Taveira, N, Teklehaimanot, B, Tekulu, G, Temsah, M, Terkawi, A, Tessema, Z, Thomas, N, Titova, M, Tlaye, K, Tohidinik, H, Tonelli, M, Tovani-Palone, M, Traini, E, Tran, K, Tripathi, M, Uddin, R, Ullah, I, Unnikrishnan, B, Upadhyay, E, Useh, U, Usman, M, Uthman, O, Vacante, M, Vaezghasemi, M, Valdez, P, Vanderheide, J, Varavikova, E, Varughese, S, Vasankari, T, Vasseghian, Y, Veisani, Y, Venkatesh, S, Venketasubramanian, N, Verma, M, Vidale, S, Violante, F, Vlassov, V, Vollmer, S, Vukovic, R, Waheed, Y, Wang, H, Wang, Y, Weldesamuel, G, Werdecker, A, Wiangkham, T, Wiens, K, Wijeratne, T, Wolde, H, Wondafrash, D, Wonde, T, Wondmieneh, A, Wu, A, Xu, G, Yadegar, A, Yadollahpour, A, Jabbari, S, Yamada, T, Yano, Y, Yaya, S, Yazdi-Feyzabadi, V, Yeshaneh, A, Yeshaw, Y, Yeshitila, Y, Yilma, M, Yip, P, Yonemoto, N, Yoon, S, Youm, Y, Younis, M, Yousefi, Z, Yousof, H, Yu, C, Yusefzadeh, H, Moghadam, T, Zaki, L, Zaman, S, Zamani, M, Zamanian, M, Zandian, H, Zarafshan, H, Zepro, N, Zerfu, T, Zewale, T, Zhang, Y, Zhang, Z, Zhao, X, Zodpey, S, Zomorodian, K, Zotor, F, Afshin, A, Hay, S, Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Value, Affordability and Sustainability (VALUE), and Microbes in Health and Disease (MHD)
- Subjects
Male ,Local patterns ,Double burden ,Börn ,Research & Experimental Medicine ,Sjúkdómseinkenni ,DOUBLE BURDEN ,Childhood overweight ,Lífefnafræði ,Læknisfræði ,0302 clinical medicine ,Syndemic ,Child ,11 Medical and Health Sciences ,under 5 years of age ,General Medicine ,3. Good health ,Geography ,Medicine, Research & Experimental ,Child, Preschool ,Income ,GROWTH ,AFRICA ,medicine.medical_specialty ,Biochemistry & Molecular Biology ,RJ ,Medicina ,Immunology ,education ,MODELS ,wa_395 ,General Biochemistry, Genetics and Molecular Biology ,Article ,03 medical and health sciences ,Humans ,Author Correction ,Developing Countries ,Poverty ,Biology ,LBD Double Burden of Malnutrition Collaborators ,Demography ,Science & Technology ,Wasting Syndrome ,Public health ,MORTALITY ,Infant ,Næringarskortur ,medicine.disease ,Obesity ,TRENDS ,signs and symptoms ,Social Class ,Risk factors ,Sameindalíffræði ,ITC-ISI-JOURNAL-ARTICLE ,UNDERNUTRITION ,Human medicine ,Clinical Medicine ,030217 neurology & neurosurgery ,Pediatric Obesity ,obesity ,Offita ,Áhættuþættir ,Geographic Mapping ,Overweight ,RA0421 ,Global health ,risk factors ,030212 general & internal medicine ,Signs and symptoms ,Wasting ,Malnutrition, Global Burden of Diseases, Global Nutrition, low- and middle-income countries ,2. Zero hunger ,1. No poverty ,Public Health, Global Health, Social Medicine and Epidemiology ,A900 Others in Medicine and Dentistry ,Childhood wasting ,PREVALENCE ,Chemistry ,Mapping ,Female ,Lýðheilsa ,medicine.symptom ,Life Sciences & Biomedicine ,GROWTH FAILURE ,Nutritional Status ,malnutrition ,ITC-HYBRID ,ws_115 ,children ,Environmental health ,medicine ,Erfðafræði ,wd_200 ,Malnutrition ,Infant, Newborn ,Klinisk medicin ,Cell Biology ,Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi ,3121 General medicine, internal medicine and other clinical medicine ,NA - Abstract
Artículo con numerosos autores, sólo se mencionan el primero, los de la UAM y grupo colectivo, A double burden of malnutrition occurs when individuals, household members or communities experience both undernutrition and overweight. Here, we show geospatial estimates of overweight and wasting prevalence among children under 5 years of age in 105 low- and middle-income countries (LMICs) from 2000 to 2017 and aggregate these to policy-relevant administrative units. Wasting decreased overall across LMICs between 2000 and 2017, from 8.4% (62.3 (55.1–70.8) million) to 6.4% (58.3 (47.6–70.7) million), but is predicted to remain above the World Health Organization’s Global Nutrition Target of, This work was primarily supported by grant OPP1132415 from the Bill & Melinda Gates Foundation awarded to S.I.H.
- Published
- 2020
16. Prévalence de l’automédication chez les étudiants universitaires: Examen systématique et méta-analyse
- Author
-
Behzadifar, Meysam, Behzadifar, Masoud, Aryankhesal, Aidin, Ravaghi, Hamid, Baradaran, Hamid Reza, Sajadi, Haniye Sadat, Khaksarian, Mojtaba, and Bragazzi, Nicola Luigi
- Abstract
Background: Self-medication can lead to serious consequences but its overall prevalence in students is not known. Aims: The aim of this study was to determine the prevalence of self-medication in students through a systematic review and meta-analysis of studies on the prevalence of self-medication in students across the world. Methods: PubMed/MEDLINE, EMBASE, ISI/Web of Science and Google Scholar were searched up to October 2017. Studies reporting the prevalence of self-treatment in university students were selected. Data recorded included year of publication, country where the study was conducted, sample size, prevalence of self-medication, sex and mean age of students, and faculty of students (medical or non-medical). A random-effect model was used to determine effect size with a 95% confidence interval (CI). Heterogeneity across studies was assessed with the I2 test. A sensitivity analysis assessed stability of the findings. Results: A total of 89 studies were included in the analysis, which comprised 60 938 students. The overall prevalence of self-medication in university students was 70.1% (95% CI: 64.3–75.4%). Female students self-medicated more often than male students: odds ratio = 1.45 (95% CI%: 1.17–1.79). The prevalence of self-medication in medical students (97.2%) was higher than in non-medical students (44.7%). The I2 test indicated high, statistically significant heterogeneity. The sensitivity analysis showed that the results were stable. Conclusion: The prevalence of self-medication among students worldwide is high. Programmes on the risks of self-medication and increasing control and monitoring of the sale of drugs are recommended. Facilitating students’ access to doctors and health centres could reduce self-medication in students.
- Published
- 2020
17. Prevalence of self-medication in university students: systematic review and meta-analysis.
- Author
-
Behzadifar, Meysam, Behzadifar, Masoud, Aryankhesal, Aidin, Ravaghi, Hamid, Reza Baradaran, Hamid, Sadat Sajadi, Haniye, Khaksarian, Mojtaba, and Luigi Bragazzi, Nicola
- Abstract
Copyright of Eastern Mediterranean Health Journal is the property of World Health Organization and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2020
- Full Text
- View/download PDF
18. Sustained release of silibinin‐loaded chitosan nanoparticle induced apoptosis in glioma cells.
- Author
-
Alipour, Maryam, Bigdeli, Mohammad, Aligholi, Hadi, Rasoulian, Bahram, and Khaksarian, Mojtaba
- Abstract
In this study, a chitosan nanoparticle formulation was synthesized for loading silibinin as a sustained‐release drug system to evaluate its effects on apoptosis in C6 glioma cells. This synthesized nanoparticle was analyzed by measurement methods including Fourier transform infrared (FTIR), field emission‐scanning electron microscopy (FE‐SEM), dynamic light scattering (DLS), X‐ray diffraction (XRD), and differential scanning calorimetry (DSC). The formation and amorphization of nanoparticle were confirmed by FTIR and XRD analysis, respectively. The mean diameter of silibinin‐loaded chitosan nanoparticles (SCNP) was 50 ± 7 and 188.6 ± 0.17 nm by using FE‐SEM and DLS, respectively. In addition, the positive zeta potential of nanoparticles was +11.5. Rhodamine‐conjugated SCNP analysis showed the internalization of silibinin to C6 glioma cells. The cytotoxicity assay indicated that the nanoformulation of silibinin was toxic to C6 glioma cells. Although SCNP significantly increased the expression of the both apoptotic genes in C6 cells, Bax and caspase3, it did not have any significant effect on the level of the antiapoptotic gene, Bcl2. In contrast, SCNP did not have any toxic effect on H9C2 cells. In conclusion, the results of the current study indicated that SCNP can be considered as a sustained‐release drug system for future cell‐based therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Accompaniment of multiple sclerosis with varicella zoster virus; a systematic review and individual participant data meta-analysis.
- Author
-
Khaksarian, Mojtaba, Masoumi, Faezeh, Ahmadi, Mahdie, Yasin Ahmadi, Seyyed Amir, and Taherikalani, Morovat
- Subjects
- *
VARICELLA-zoster virus , *MULTIPLE sclerosis , *META-analysis , *CEREBROSPINAL fluid , *BLOOD cells - Abstract
Numerous studies and meta-analyses have been conducted on the role of infectious agents in susceptibility to multiple sclerosis (MS). In this study we aimed to investigate the role of varicella zoster virus (VZV) in susceptibility to MS as an individual participant data (IPD) meta-analysis. After screening and applying eligibility criteria 19 studies were imported for qualitative systematic review and 11 studies were imported for meta-analysis as different subgroups. No significant result was obtained for association of VZV IgG seropositivity with susceptibility to MS. Positive history of VZV infection was significantly associated with susceptibility to MS. Synthesis of IPD showed that presence of VZV DNA was associated with MS(P<0.001) both in peripheral blood mononuclear cells (OR= 22.40 [5.85-85.71]) and in cerebrospinal fluid (OR= 14.42 [5.29-39.29]). In general VZV can be a risk factor for MS; but since VZV infection history is highly prevalent in populations without vaccination and on the other hand MS has low prevalence, this association should not be used as a prognostic or predictive value. The exact mechanism should be investigated in future. [ABSTRACT FROM AUTHOR]
- Published
- 2019
20. Overview of the Therapeutic Effects of Origanum vulgare and Hypericum perforatum Based on Iran's Ethnopharmacological Documents.
- Author
-
BAHMANI, MAHMOUD, KHAKSARIAN, MOJTABA, RAFIEIAN-KOPAEI, MAHMOUD, and ABBASI, NASER
- Subjects
- *
HYPERICUM perforatum , *HERBAL medicine , *OREGANO , *THERAPEUTICS - Abstract
Herbs have played an important role in the health and wellness of human beings. Nowadays, medicinal herbs are at the forefront of studies of medical science because of their importance in public health. Understanding the traditional and therapeutic effects of medicinal plants is important because they can be effective as a source of medication. Based on the results obtained from the review of Iran's ethnopharmacological literature, it was found that the Origanum vulgare can be used as energy producer, diuretic, stomach booster, nervous system reliever, laxative, anticancer, relief of migraine, fracture healing, numbness of organs, relief of toothache, disinfectant, anticonvulsant, expectorant, analgesic, antitussive, anti-inflammatory, menstrual regulator, decreases urinary tract infection, treatment of sexual dysfunction, colic, sinusitis, cardiac tonic and blockage remover. Also, Hypericum perforatum is used as a digestive and nervous system relaxant, respiratory and uterine stimulant, a booster of the immune system, antidepressant, anticancer, anti-AIDS, analgesic, bile cathartic, relaxing, anti-tussive, analgesic, treating nervous system diseases, astringent, antiparasitic, expectorant, diuretic, and blood pressure regulator. Preliminary results presented in this review study enlighten us that the herbal plants could be the basis for experimental and clinical studies to promote the use of natural agents in the treatment of human diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
21. Associated functional motor recovery induced by Intracerebroventricular (ICV) microinjection of Wharton's jelly mesenchymal stem cells following brain ischemia/reperfusion injury in rat: Decreased dark neurons and Bax gene expression in the cerebral cortex
- Author
-
Alizamir, Tahereh, Akbari, Mohammad, Mokhtari, Tahmineh, khaksarian, Mojtaba, and Hassanzadeh, Gholamreza
- Subjects
MICROINJECTIONS ,MESENCHYMAL stem cells ,REPERFUSION injury ,BAX protein ,APOPTOSIS - Abstract
Objectives Stroke is a situation caused activation of some events leading to neuronal damage and death. The proteins of Bcl-2-family are important in regulation of cell death and life. Bax, as a Bcl-2-interacting protein, is a member of this family which promotes apoptosis and cell death. Some therapeutic approaches have been introduced for the treatment of ischemic brain injury. Neuroprotection is one of the approaches for diminishing neurological deficits. We investigated the effects of intracerebroventricular (ICV) injection of Wharton's jelly mesenchymal stem cells (WJ-MSCs) on the cortex of the brain in ischemic rats. Methods In this study, we occlude the middle cerebral artery (MCA) for induction of ischemic stroke in the brain. Rats were classified in four groups of Co, Sh, MCAo and MCAo + WJ-MSCs. Single dose of intraventricular microinjection of WJ-MSCs was injected by a Hamilton syringe. For detecting behavioral outcomes in the rats, Neurological examination was carried out. After 21 days, the animals were sacrificed and their brain tissues were removed for histopathological and molecular analysis. Results ICV microinjection of WJ-MSCs significantly prevented apoptosis and cell death compared with MCAo group. A significant reduction in the level of Bax gene expression was observed in the MCAo + WJ-MSCs as group compared with Co, Sh and MCAo groups (P < 0.05). H&E staining showed considerable reduction of dark neurons in MCAo + WJ-MSCs group rather than Co, Sh and MCAo groups (P < 0.05). Conclusions The results of the current study suggest that ICV microinjection of WJ-MSCs had neuroprotective effects on the brain cortex of ischemic rats by reduction of the Bax gene expression level and the number of dark neurons. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. Brain Derived Neurotrophic Factor Modification of Epileptiform Burst Discharges in a Temporal Lobe Epilepsy Model.
- Author
-
Eftekhari, Sanaz, Mehrabi, Soraya, Karimzadeh, Fariba, Joghataei, Mohammad-Taghi, Khaksarian, Mojtaba, Hadjighassem, Mahmoud Reza, Katebi, Majid, and Soleimani, Mansooreh
- Subjects
BRAIN-derived neurotrophic factor ,TEMPORAL lobe epilepsy ,LABORATORY rats ,THERAPEUTICS ,EPILEPTIFORM discharges - Abstract
Introduction: Transforming Growth Factor-Beta 1 (TGF-β1) is a pleiotropic cytokine with potent anti-inflammatory property, which has been considered as an essential risk factor in the inflammatory process of Ischemic Stroke (IS), by involving in the pathophysiological progression of hypertension, atherosclerosis, and lipid metabolisms. -509C/T TGF-β1 gene polymorphism has been found to be associated with the risk of IS. The aim of this meta-analysis was to provide a relatively comprehensive account of the relation between -509C/T gene polymorphisms of TGF-β1 and susceptibility to IS. Methods: Male Wistar rats were divided into sham (receiving phosphate buffered saline within dorsal hippocampus), pilocarpine (epileptic model of TLE), single injection BDNF (epileptic rats which received single high dose of BDBF within dorsal hippocampus), and multiple injections BDNF (epileptic rats which received BDNF in days 10, 11, 12, and 13 after induction of TLE) groups. Their electrocorticogram was recorded and amplitude, frequency, and duration of spikes were evaluated. Results: Amplitude and frequency of epileptiform burst discharges were significantly decreased in animals treated with BDNF compared to pilocarpine group. Conclusion: Our findings suggested that BDNF may modulate the epileptic activity in the animal model of TLE. In addition, it may have therapeutic effect for epilepsy. More studies are necessary to clarify the exact mechanisms of BDNF effects. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
23. Curcumin as a double-edged sword for stem cells: dose, time and cell type-specific responses to curcumin.
- Author
-
Attari, Fatemeh, Zahmatkesh, Maryam, Aligholi, Hadi, Mehr, Shahram Ejtemaei, Sharifzadeh, Mohammad, Gorji, Ali, Mokhtari, Tahmineh, Khaksarian, Mojtaba, and Hassanzadeh, Gholamreza
- Subjects
CELL proliferation ,ANIMAL experimentation ,BONE marrow ,CULTURE media (Biology) ,DOSE-response relationship in biochemistry ,IMMUNOASSAY ,RATS ,STEM cells ,TIME ,CURCUMIN - Abstract
Background: The beneficial effects of curcumin which includes its antioxidant, anti-inflammatory and cancer chemo-preventive properties have been identified. Little information is available regarding the optimal dose and treatment periods of curcumin on the proliferation rate of different sources of stem cells. Methods: In this study, the effect of various concentrations of curcumin on the survival and proliferation of two types of outstanding stem cells which includes bone marrow stem cells (BMSCs) and adult rat neural stem/progenitor cells (NS/PCs) at different time points was investigated. BMSCs were isolated from bilateral femora and tibias of adult Wistar rats. NS/PCs were obtained from subventricular zone of adult Wistar rat brain. The curcumin (0.1, 0.5, 1, 5 and 10 µM/L) was added into a culture medium for 48 or 72 h. Fluorescent density of 5-bromo-2'-deoxyuridine (Brdu)-positive cells was considered as proliferation index. In addition, cell viability was assessed by MTT assay. Results: Treatment of BMSCs with curcumin after 48 h, increased cell survival and proliferation in a dose-dependent manner. However, it had no effect on NSCs proliferation except a toxic effect in the concentration of 10 µM of curcumin. After a 72 h treatment period, BMSCs and NS/PCs survived and proliferated with low doses of curcumin. However, high doses of curcumin administered for 72 h showed toxic effects on both stem cells. Conclusions: These findings suggest that curcumin survival and proliferative effects depend on its concentration, treatment period and the type of stem cells. Appropriate application of these results may be helpful in the outcome of combination therapy of stem cells and curcumin. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
24. cAMP-Epac Pathway Stimulation Modulate Connexin-43 and MicroRNA-21 Expression in Glioma Cells.
- Author
-
Mostafavi, Hossein, Khaksarian, Mojtaba, Joghataei, Mohammad Taghi, Yoosefee, Sadegh, Soleimannejad, Maryam, Gholamzadeh, Raheleh, Bahnamiri, Sanam Seifollahi, and Hadjighassem, Mahmoud Reza
- Subjects
- *
GLIOMAS , *CONNEXIN 43 , *MICRORNA - Abstract
Introduction: Malignant astrocytic gliomas are the most common and lethal brain malignancies due to their refractory to the current therapies. Nowadays, molecular targeted therapy has attracted great attention in treatment of glioma. Connexin 43 (Cx43) and micro ribonucleic acid- 21(miR-21) are among molecules that are involved in glioma development and progression. These molecules showed potential to be as target molecules with regard to glioma. Some studies have reported that cyclic adenosine monophosphate (cAMP) signaling could be effective on Cx43 and miR-21 in tissues other than in brain. We investigate possible relationship between β-adrenergic receptor and its newly described downstream, exchange protein directly activated by cAMP (Epac) signaling pathway and expression of Cx43 and miR-21 in low (1321N1) and high grade (U87MG) glioma cell lines. Methods: We treated cells with β-adrenergic agonist and Epac activator with and without adenyl cyclase inhibitor. Cx43 and miR-21 expression were measured with real-time PCR. Results: Our data showed that in 1321N1 cells, β-adrenergic-Epac pathway stimulation up and down-regulated Cx43 and miR-21 expression respectively. Whereas, in U87MG cells these interventions had no effect on Cx43 and miR-21 expression. Discussion: These findings demonstrate that low grade astrocytoma cells have better response to our pharmacological interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2015
25. Selective β2 adrenergic agonist increases Cx43 and miR-451 expression via cAMP-Epac.
- Author
-
MOSTAFAVI, HOSSEIN, KHAKSARIAN, MOJTABA, TAGHI JOGHATAEI, MOHAMMAD, SOLEIMANI, MASOUD, HASSANZADEH, GHOLAMREZA, EFTEKHARI, SANAZ, SOLEIMANI, MANSOOREH, MOUSAVIZADEH, KAZEM, ESTIRI, HAJAR, AHMADI, SEDIGHESADAT, and REZA HADJIGHASSEM, MAITMOUD
- Subjects
- *
CONNEXINS , *MICRORNA , *CYCLIC adenylic acid , *CELL proliferation , *ASTROCYTOMAS - Abstract
It has been demonstrated that connexin 43 (Cx43) and microRNAs have significant roles in glioma. Cyclic adenosine monophosphate (cAMP) is suggested to be a regulator of connexins and microRNAs. However, it remains elusive whether cAMP and exchange protein directly activated by cAMP (Epac2), have a regulatory effect on Cx43 and microRNA-451 (miR-451) in astrocytoma cells. We treated 1321N1 astrocytoma cells with a selective β2 adrenergic agonist and a selective Epac activator with and without adenyl cyclase and protein kinase A inhibition. Cx43 and miR-451 expression were measured. Next, we evaluated the effect of miR-451 over-expression on Cx43 expression. Cell proliferation was measured using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The results demonstrated that cAMP-Epac2 increased Cx43 and miR-451 expression. However, the alteration of miR-451 expression required a higher dose of drugs. Overexpression of miR-451 had no significant effect on Cx43 expression. The MTT assay showed that cAMP-Epac stimulation and miR-451 overexpression had a synergic inhibitory effect on cell proliferation. These findings may expand our understanding of the molecular biology of glioma and provide new potential therapeutic targets. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
26. Fluoxetin Upregulates Connexin 43 Expression in Astrocyte.
- Author
-
Mostafavi, Hossein, Khaksarian, Mojtaba, Joghataei, Mohammad Taghi, Hassanzadeh, Gholamreza, Soleimani, Masoud, Eftekhari, Sanaz, Soleimani, Mansooreh, Mousavizadeh, Kazem, and Hadjighassem, Mahmoud Reza
- Subjects
- *
FLUOXETINE , *CONNEXIN 43 , *ASTROCYTES - Abstract
Introduction: Recent studies have shown that astrocytes play major roles in normal and disease condition of the central nervous system including multiple sclerosis (MS). Molecular target therapy studies in MS have revealed that connexin-43 (Cx43) and Aquaporin-4 (AQP4) contents of astrocytes undergo expression alteration. Fluoxetine had some effects in MS patients unrelated to its known antidepressant effects. Some of fluoxetine effects were attributed to its capability of cAMP signaling pathway stimulation. This study aimed to investigate possible acute effects of fluoxetine on Cx43 and AQP4 expression in astrocyte. Methods: Astrocytoma cells were treated for 24 hours with fluoxetine (10 and 20 µg/ml) with or without adenyl cyclase (AC) and protein kinase A (PKA) inhibition. Cx43 expression at both mRNA and protein levels and AQP4 expression at mRNA level were evaluated. Results: Acquired results showed that fluoxetine with and without AC and PKA inhibition resulted in Cx43 up-regulation both in mRNA and protein levels, whereas AQP4 expression have not changed. Discussion: In conclusion, data showed that fluoxetine alone and in the absence of serotonin acutely up-regulated Cx43 expression in astrocytes that can be assumed in molecular target therapy of MS patients. It seems that cAMP involvement in fluoxetine effects need more researches. [ABSTRACT FROM AUTHOR]
- Published
- 2014
27. Sleep Disturbances Rate among Medical and Allied Health Professions Students in Iran: Implications from a Systematic Review and Meta-Analysis of the Literature.
- Author
-
Khaksarian, Mojtaba, Behzadifar, Masoud, Behzadifar, Meysam, Jahanpanah, Firuzeh, Guglielmi, Ottavia, Garbarino, Sergio, Lanteri, Paola, Re, Tania Simona, Zerbetto, Riccardo, Maldonado Briegas, Juan José, Riccò, Matteo, and Bragazzi, Nicola Luigi
- Published
- 2020
- Full Text
- View/download PDF
28. The effects of peripheral and central administration of hypericum perforatum L and the role of alpha-adernergic system.
- Author
-
Biranvand, Fazaneh and Khaksarian, Mojtaba
- Subjects
HYPERICUM perforatum ,PLANT extracts ,ADRENERGIC alpha blockers ,PAIN management ,NEUROTRANSMITTERS - Abstract
Background In this study, the effect of peripheral and central administration of aqueous extract Hypericum Perforatum L (HP) on acute and chronic pain models using formalin and tail flick tests were evaluated. Materials and methods At first stage, for assessment of the antinociceptive effect intraperitoneal (i.p) of different dose of HP were used, in later stage, for central effects Hp was filtered and administrated intrathecal (i.t) and intracerebroventricular(i.c.v) and the last, Yohimbine and Prazocin were administrated before i.p injection of it. Results HP (i.p) with the above mentioned doses significantly produced analgesia in both tests. HP induced analgesia in the first phase of formalin and tail flick tests, while at higher dose produced analgesia in both phases of formalin and tail flick tests. The i.c.v administration of HP produced analgesia in both phases of formalin test, while it had no effect on tail flick latency. Yohimbine significantly reversed antinociceptive effect HP in the first phase of formalin test. Prazocin had no significant effect on formalin and tail flick tests. Conclusions According to our results peripheral and central administration of HP can produced analgesia. HP has an antinociceptive effect at spinal and central levels, and spinal effect seems to be more potent. Further investigation of the role of other neurotransmitter system such as opioidergic and serotonergic system is recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
29. Comparison of Vitamin D, Neurofeedback, and Neurofeedback Combined with Vitamin D Supplementation in Children with Attention-Deficit/Hyperactivity Disorder.
- Author
-
Rahmani, Masoud, Mahvelati, Azadeh, Farajinia, Amir Hossein, Shahyad, Shima, Khaksarian, Mojtaba, Nooripour, Roghieh, and Hassanvandi, Saba
- Subjects
- *
TREATMENT of attention-deficit hyperactivity disorder , *THERAPEUTIC use of vitamin D , *ACADEMIC medical centers , *BIOFEEDBACK training , *ATTENTION-deficit hyperactivity disorder , *DIETARY supplements , *TREATMENT effectiveness , *RANDOMIZED controlled trials , *PSYCHOLOGICAL tests , *COMPARATIVE studies , *REPEATED measures design , *DESCRIPTIVE statistics , *COMBINED modality therapy , *STATISTICAL sampling , *EVALUATION , *CHILDREN - Abstract
Background: Nowadays, some treatments such as neurofeedback and Vitamin D Supplementation are of great importance in the treatment of attention-deficit/hyperactivity disorder (ADHD). To determine the efficacy of the combined treatment, the present trial was conducted to investigate the effectiveness of each one of them with combined neurofeedback and vitamin D supplementation in the reduction of ADHD symptom in children suffering from this disorder. Methods: In this study from March 2020 to June 2020, we enrolled a total of 120 patients (6-15 years old) who were referred to the Mehr psychiatric hospital (affiliated to Lorestan University of Medical Sciences). Patients were then randomly categorized into three experimental groups and one control group. The first, the second, and the third experimental groups consumed vitamin D pearl, neurofeedback combined with vitamin D, and neurofeedback for 12 weeks, respectively. The control group was given no treatment. Vitamin D serum level was evaluated at baseline, 4, 8, and 12 weeks in all participants. For data collection, the Parent Attention-Deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) was applied. The obtained information was analyzed using repeated measure variance analysis. Results: The mean scores were significantly different across the groups. Repeated measure variance analysis showed that the mean score was lower in the combined group in comparison with the other three groups (P < 0.05). Conclusion: Combined treatment could be considered as more effective compared to separate treatments. In addition, in this study, by applying the combined intervention, the duration of treatment decreased significantly. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Protective Effects of Honey, Apis mellifera Meda Skorikov, on Ischemia-Reperfusion Induced Muscle Injury.
- Author
-
Reza Gholami, Mohammad, Abbaszadeh, Abolfazl, Anbari, Khatereh, Khaksarian, Mojtaba, Shabooni, Fatemeh, Khanipour Khayat, Zahra, Mohammadrezaei Khorramabadi, Reza, and Mohammad Gharravi, Anneh
- Subjects
- *
HONEYBEES , *MUSCLE injuries , *HONEY , *SKELETAL muscle , *TOLUIDINE blue - Abstract
Honey is a natural antioxidant that its protective effects have been proven against ischemia-reperfusion (IR) injury. The aim of this study was to evaluate the ameliorative effect of Persian Honey, Apis mellifera meda skorikov, on gastrocnemius muscle IR injury. Eighty adult male Sprague-Dawley rats weighing 250-300 g were used. They were divided into ten groups (N=8 per group). The ischemia was conducted with a silk suture 6-0 using the slipknot technique. All groups were rendered in ischemic for 3 h, and reperfused for various times of 3 days (3-day reperfusion), 7 days (7-day reperfusion), 14 days (14-day reperfusion), and 28 days (28-day reperfusion). Half of the groups had experimental honey (5 %) treatment immediately after ischemia. After reperfusion, the rats, based on the grouping, were killed with high doses of anesthetic, and the gastrocnemius muscles were removed and fixed. After the tissue processing, the evaluation of edema and mast cells infiltration was performed with hematoxylin-eosin and toluidine blue staining, respectively. TNF-a was detected with immunohistochemistry method. The amount of TNF-a as an index of acute inflammatory except the 3rd day significantly decreased on the other day of reperfusion (7th, 147th and 287th days). The mast cells infiltration was significantly decreased on 77th and 147th days. The tissue edema was decreased significantly in honey administrated group in the comparison with placebo groups. Honey administration can reduce damage caused by ischemia-reperfusion in the rat gastrocnemius muscle. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
31. Applying Vasopressin-Pre-Conditioned Human Adipose Mesenchymal Stem Cells Improves Heart Condition after Transplantation into Infarcted Myocardium.
- Author
-
Nasiri Boroujeni S, Chehelcheraghi F, Khaksarian M, Sedighi M, Ghorbanzadeh V, and Nazari A
- Abstract
Transplantation of H-AdMSCs may improve heart function after MI. AVP is a neurohypophyseal hormone that reduces cardiovascular damage. This study investigated the role of AVP preconditioning in the survival of MSCs and their effect on myocardial repair in the MI rats. H-AMSCs were isolated and incubated for 3 days. The expression of oxytocin and vasopressin receptors was evaluated by Real-time-PCR. Forty male Wistar rats were divided into 4 groups: control, sham, ASC and AVP-ASC. Ischemia was established by ligation of LAD coronary artery. Electrocardiography, fibrosis, angiogenesis, and apoptosis in myocardium were determined after 7 days. Results showed that preconditioned MSCs significantly increased cardiac function when compared with group that received non-preconditioned MSCs. This was associated with significantly reduced fibrosis, increased vascular density, and decreased resident myocyte apoptosis. Results indicate that AVP preconditioned MSCs can be consider a novel approach to management of MI.
- Published
- 2022
- Full Text
- View/download PDF
32. Effect of Nectaroscordum koelzi Methanolic Extract on Acute and Chronic Inflammation in Male Mice.
- Author
-
Khaksarian M, Mahmoudvand H, Alipour M, Naizi M, Hasanvand KH, and Nadri S
- Subjects
- Acetic Acid administration & dosage, Acetic Acid toxicity, Animals, Anti-Inflammatory Agents isolation & purification, Anti-Inflammatory Agents therapeutic use, Capillary Permeability drug effects, Capillary Permeability immunology, Disease Models, Animal, Ear blood supply, Edema chemically induced, Edema immunology, Edema pathology, Humans, Inflammation immunology, Male, Methanol chemistry, Mice, Plant Extracts isolation & purification, Plant Extracts therapeutic use, Xylenes administration & dosage, Xylenes toxicity, Allium chemistry, Anti-Inflammatory Agents pharmacology, Edema drug therapy, Inflammation drug therapy, Plant Extracts pharmacology
- Abstract
Introduction: The present study deals with the effect of Nectaroscordum koelzi fruit extract on acute and chronic inflammation., Methods: A total of 84 NMRI mice were used in this study. The effect of the extract on acute inflammation was analyzed by increasing vascular permeability via acetic acid and xylene induced ear edema among mice. The extract was evaluated in terms of effects on chronic inflammation by means of the cotton pellet test among mice. For the assessment of inflammation degree, the mice paw edema volume was measured by the plethysmometric test., Results: The findings showed that the extract was effective on acute inflammation induced by acetic acid in mice. In the xylene ear edema, N. koelzi extract indicated a significant activity in mice. In the cotton pellet method, the methanol extract produced a significant reduction in comparison with the control and dexamethasone. Mice paw edema volume decreased with the extract., Conclusion: In general, the data from the experiments indicated that the methanol extract of N. koelzi has an anti-inflammatory effect on acute and chronic inflammation. However, the exact contributing mechanisms have not been investigated for the pharmacological effects., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2021
- Full Text
- View/download PDF
33. Cancer stem cells and nanotechnological approaches for eradication.
- Author
-
Basati G, Khaksarian M, Abbaszadeh S, Lashgarian HE, and Marzban A
- Abstract
Cancer stem cells (CSCs) are currently known as the main cause of tumor recurrence. After chemotherapy is completed, CSCs proliferate and then differentiate to generate new tumor tissues. Similar to normal stem cells, this non-uniformly distributed cell population in the tumor tissue has self-renewal capacity and is responsible for survival of the tumor and difference in its genetic and metabolic characteristics. Followed by gene instability in CSCs, new phenotypic markers are aberrantly expressed in CSCs subpopulation. Hence, some of the surface markers and metabolic pathways that are upregulated in CSCs may be applied as specific targets for development of diagnostic and therapeutic approaches. In this review article, the distinctive properties of CSCs including signal pathways implicated in self-renewal and surface markers were discussed. Moreover, targeting CSCs based on their specific properties using nanodrugs was reviewed., Competing Interests: Conflicts of Interest: The authors have no conflicts of interest to declare., (2019 Stem Cell Investigation. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
34. The synergistic effect of hydroalcoholic extracts of Origanum vulgare , Hypericum perforatum and their active components carvacrol and hypericin against Staphylococcus aureus .
- Author
-
Bahmani M, Taherikalani M, Khaksarian M, Rafieian-Kopaei M, Ashrafi B, Nazer M, Soroush S, Abbasi N, and Rashidipour M
- Abstract
Aim: This study was designed to evaluate the synergistic activities of hydroalcoholic extracts of medicinal plants Origanum vulgare and Hypericum perforatum and their active components, carvacrol and hypericin against Staphylococcus aureus ., Methods: The synergistic effects of the plants, as well as carvacrol and hypericin, were examined using a checkered method against S. aureus (ATCC 12600)., Results: A fractional inhibitory concentration of 0.5 was obtained for combination of O. vulgare and H. perforatum and 0.49 for combination of the active ingredients carvacrol and hypericin, both of which indicated a synergistic effect., Conclusion: This preliminary evaluation demonstrated a synergistic property of O. vulgare and H. perforatum extracts in treating S. aureus infection. This study indicates that combination of the plants, as well as combination of carvacrol and hypericin, might be used as a new antibacterial strategy against S. aureus ., Competing Interests: Financial & competing interests disclosure This study was funded by the Research and Technology Deputy of Lorestan University of Medical Sciences, Khorramabad, Iran. No. A-10-1379-1. The authors would like to express their gratitude for financial support of the Research and Technology Deputy of Lorestan University of Medical Sciences, Khorramabad, Iran. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
- Published
- 2019
- Full Text
- View/download PDF
35. Phytochemical Profiles and Antibacterial Activities of Hydroalcoholic Extracts of Origanum vulgare and Hypericum perforatum and Carvacrol and Hypericin as a Promising Anti-Staphylococcus aureus.
- Author
-
Bahmani M, Taherikalani M, Khaksarian M, Soroush S, Ashrafi B, and Heydari R
- Subjects
- Anthracenes, Anti-Bacterial Agents isolation & purification, Anti-Bacterial Agents pharmacology, Candida albicans drug effects, Chromatography, High Pressure Liquid, Cymenes, Escherichia coli drug effects, Hypericum metabolism, Microbial Sensitivity Tests, Monoterpenes pharmacology, Origanum metabolism, Perylene chemistry, Perylene pharmacology, Phytochemicals isolation & purification, Phytochemicals pharmacology, Plant Extracts chemistry, Solid Phase Microextraction, Staphylococcus aureus drug effects, Anti-Bacterial Agents chemistry, Hypericum chemistry, Monoterpenes chemistry, Origanum chemistry, Perylene analogs & derivatives, Phytochemicals chemistry
- Abstract
Objectives: Staphylococcus aureus, a Gram-positive bacteria, is ranked second among the causes of hospital infections and is one of the three main causes of food poisoning. In recent times, the spread of antibiotic resistance in S. aureus has become very worrisome. Therefore, research for new effective drugs is important. The present study aims to investigate the phytochemical profiles and antibacterial effects of hydroalcoholic extracts of Origanum vulgare (Lamiaceae family) and Hypericum perforatum (Clusiaceae family) and their active compounds on S. aureus (ATCC 12600) in vitro., Methods: The identification of phytochemical compounds in both plants was performed by Highperformance liquid chromatography (HPLC), headspace-solid-phase microextraction (HS-SPME) and Fourier-transform infrared spectroscopy (FTIR). To investigate microbial susceptibility, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and disc diffusion method (DAD) were used. Finally, the results of the study were compared with methicillin., Results: Of the 42 combinations of O. vulgare, carvacrol (48%) and of the 38 combinations of H. perforatum, hypericin (46.2%) were the most abundant. The MIC, MBC and DAD of O. vulgare and H. perforatum, carvacrol, hypericin and methicillin were 625, 625, 312.5, 78.12 and 384 µg/mL, 10000, 10000, 2500, 2500 and 384 µg/mL, and 15.66 ± 4.49, 12.66 ± 0.47 and 22 ± 0.81 mm, respectively., Conclusion: Due to the significant effects of O. vulgare and H. perforatum and their active components against S. aureus, it is expected that in the future, hypericin, carvacrol and their derivatives can be used as effective antibacterial agents against S. aureus., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.